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ABSTRACT 
Submicrometer sized particles are being extensively studied because of their potentials to 
deliver various molecular drugs and imaging contrast agents to target diseased tissue and also 
support electrocatalytic activities of metallic particles. Successful use of nanoparticles in these 
biological and energy applications greatly depends on the ability to control the structural 
integrity and the surface functionality of nanoparticles. Innumerable methods to assemble 
bioactive or electrocatalytic nanocarriers were proposed to dates; however, most approaches 
accompany complex chemistry and multiple purification, thus reducing production yield while 
increasing costs. Therefore, the goal of this thesis research was to develop a simple but advanced 
method to control the lifetime and surface functionality of nanocarriers. Along this line, the 
thesis presents three different approaches: 1) To extend bioavailability of nanocarriers labeled 
with a near infrared (NIR) probe by decreasing the nanoparticle bilayer permeability and 
subsequently enhance the quality of tumor detection (Chapter 2); 2) To functionalize the 
nanocarrier surface with a wide array of antibodies in a simple yet elaborate bio-inspired 
approach (Chapter 3); 3) To improve electrocatalytic activities of polymeric micelles via surface 
coating with platinum nanocubes (Chapter 4). Overall, the results of this thesis study would 
greatly serve to allow us to engineer the function of nanocarriers in a simple and economic 
manner, and expedite their uses in a wide array of applications.  
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Chapter 1 Introduction 
1.1 Motivation and Background 
The targeted delivery of imaging contrast agents and drugs has been extensively studied to 
improve the quality of diagnoses and treatments of various chronic and malignant diseases. 
Specifically, nano-sized polymeric micelles and polymeric vesicles, often called polymersomes, 
have been increasingly studied for use in the targeted delivery of biomedical molecules.   
Polymeric micelles, considerably more stable than surfactant micelles, were proposed as an 
exciting nanocarrier system in 1976.1 Polymeric micelles are usually formed by self-associating of 
amphiphilic polymers with distinguished hydrophobic and hydrophilic segments into core/shell 
structures in aqueous solution. By conjugating targeting ligand molecules to the micelle surface, 
numerous immunomicelles have been prepared and demonstrated high binding specificities and 
targetabilities as summarized in the review papers.2, 3  
Polymersomes, a relatively new term which was coined in 1999,4 also formed a structure with 
aqueous solution in the core by the self-assembly of amphiphilic polymers. This unique 
architecture enables the hydrophilic lumen to load and protect sensitive biomedical agents, while 
the polymersome membrane provides a physical barrier for the encapsulated agent from external 
materials and may be modified with peptide or antibody to serve as the active-targeting surface.  
Various amphiphilic polymers, including block copolymers and graft copolymers (or referred 
to as comb copolymer),5 have been studied for constructing polymeric micelles and polymersomes. 
Looking back at the history of nanomedicine, block copolymers, such as Pluronics, have been 
demonstrated as a promising material system for constructing nanocarriers.4 However, some 
limitations of nanocarriers made of block polymers remain to be overcome, including the limited 
functionality of the polymers and many purification steps for the polymer synthesis. Therefore, a 
2 
biocompatible graft copolymer, which features easy functionalizations, and a designed assembly 
strategy will allow us to overcome the limitations of current polymeric nanocarriers. 
Polyaspartamide, a class of graft copolymers 1  prepared by aminolysis of the starting 
polysuccinimide backbone with reactive grafts (either small molecules or polymers with amine 
functional groups), demonstrates the compositional flexibility and the relative simple polymer 
synthesis compared to block copolymers. Polyaspartamide has been explored by Giammona et. al. 
and Kim et. al., particularly for its applications as micellar drug carriers,6-11 micellar imaging 
probe carriers,12-14 and multi-functional micellar carriers.15 Increasing the hydrophobic graftings 
of polyaspartamide to form polyaspartamide polymersomes, though still at its early stage, has also 
been demonstrated experimentally and theoretically.16-18 In summary, this copolymer system can 
be altered and functionalized for various purposes and has more potential to be explored, 
considering its flexibility of the synthetic chemistry. 
 
1.2 Research Overview 
The goal of this dissertation research is to engineer an amphiphilic polyaspartamide to 
prepare nanocarriers for imaging contrast agents and catalytic platinum nanocubes, aiming to 
achieve the improved targetability and lifetime when the nanocarriers are used in the targeted 
delivery and to reach the enhanced catalytic performance when used as the catalyst support. Three 
research projects are presented in this dissertation accordingly. 
In Chapter 2, decreasing the polymersome bilayer permeability will be demonstrated to 
extend the polymersome lifetime in blood stream and to improve the enhanced permeability and 
                                                 
1
 The author will refer to polyaspartamide as graft “polymer” in the following chapters, instead of graft “copolymer”. 
This is because the grafted groups on polyaspartamide are not involved in the polymer chain growth in this 
dissertation.  
3 
retention (EPR) effect for bioimaging in a murine inflammation model, when the polymersome 
coupled with a near infrared (NIR) probe. Self-assembled nanoparticles conjugated with various 
imaging contrast agents have been used for the detection and imaging of pathologic tissues. 
Inadvertently, these nanoparticles undergo fast, dilution-induced disintegration in circulation and 
quickly lose their capability to associate with and image the site of interest. In this chapter, 
poly(2-hydroxyethyl-co-octadecyl aspartamide), sequentially modified with methacrylate groups, 
will be used to build model polymersomes and to tackle this challenge. 
In Chapter 3, a strategy of functionalizing the nanoparticle surface with a wide array of 
antibodies as the targeting motif via the modular self-assembly of antibodies and alkylated protein 
A with polyaspartamide micelles will be investigated. Delivering nanocarriers of functional 
molecules to the sites of interest is a common demand for various biomedical applications. The 
surfaces of nanocarriers are usually chemically modified with molecules that can specifically bind 
with the target site. However, this approach requires multiple chemical modification and 
purification steps, thus raising concerns on the production yield and cost. To resolve the challenge, 
poly(2-hydroxyethyl-co-octadecyl aspartamide) (PHEA-g-C18) will be used to build the 
bacterium-mimicking nanoparticle surface, which is easily functionalized with different targeting 
antibodies, in this chapter. 
In Chapter 4, the amphiphilic polyaspartamide will be applied to carry the catalytic platinum 
nanocubes by two different preparation methods. The effect of polymer interaction with the 
nanocubes on the catalytic performance of the nanoconstruct will be studied. Limited effective 
approaches of immobilizing Pt nanocubes on a solid support of interest have been studied, thus 
restraining the wide application of Pt nanocubes. To resolve the challenge, this chapter will 
demonstrate a method to associate the nanocubes with PHEA-g-C18 polymeric micelles, which 
4 
later bring the nanocubes to coat on the electrode, and will explore the distinct spatial organization 
of the Pt-PHEA-g-C18 nanoconstructs and the resulting impact on the catalytic performance.  
In Chapter 5, the main findings from the research projects in Chapter 2, Chapter 3, and 
Chapter 4 will be summarized. The experimental suggestions based on the three chapters will also 
be included for the future research on polyaspartamide designs and applications. 
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Chapter 2 Tailoring Polymersome Bilayer Permeability Improves 
Enhanced Permeability and Retention Effect for Bioimaging2 
2.1 Introduction 
Extensive efforts have been made to detect pathologic tissues (i.e., proinflammatory tissue, 
tumor) at an early stage, as treatment is more effective when they are found early.1, 2 Common 
methods of diagnosis currently include biochemical screening of blood samples or whole body 
imaging.3 Specifically, whole body imaging offers several advantages, including the ability to 
locate the pathologic tissue and further assess therapeutic outcomes in a non-invasive manner.  
Biomedical imaging techniques that are used commonly in preclinical and clinical settings, 
including magnetic resonance imaging,4 optical coherence tomography,5, 6 and near-infrared 
(NIR) fluorescence imaging,7, 8 often employ molecules or nanoparticles that can provide 
enhanced image contrast.4-8 Furthermore, efforts are increasingly made to deliver these imaging 
contrast agents exclusively to the target tissue in order to pinpoint it using conventional imaging 
modalities.  
One popular approach is to conjugate imaging contrast agents to nanoparticles that can 
diffuse through the leaky inflamed or tumor vasculature and accumulate in the extravascular 
tissue, termed as the enhanced permeation and retention (EPR) effect.9, 10 Alternatively, 
nanoparticles conjugated with ligands can bind actively with receptors overexpressed by target 
pathologic cells.4-6 Integrating the EPR effect with the active targeting is also being explored in 
the design of advanced nanoparticles targeting tissues of interest. These efforts, however, are 
often plagued by the limited circulation time of the self-assembled nanoparticles in vivo.11 For 
                                                 
2
 Reproduced with permission from ACS Applied Materials & Interfaces 2014, 6, 10821-10829 (DOI: 
dx.doi.org/10.1021/am502822n). Copyright 2014 American Chemical Society. 
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example, in mice and rats, nanoparticles should continue circulating for at least 6 hours to 
achieve the desired EPR effect.12 Accordingly, a variety of approaches have been developed to 
increase the circulation time of nanoparticles equipped with imaging contrast agents in the 
bloodstream. For instance, the nanoparticle surface is conjugated with poly(ethylene glycol) 
(PEG) to reduce the mononuclear phagocyte system-mediated clearance.13 Separately, the 
molecular weights of nanoparticle-forming molecules can be tailored to improve the structural 
integrity of nanoparticles: Nanoparticles formed from the self-assembly of high molecular 
weight polymers remained more stable than small molecular weight molecules, such as lipids 
and surfactants.14 These approaches are often combined together to attain synergistic 
improvements of the particle stability. 
However, self-assembled polymeric micelles were still reported to disintegrate quickly in 
the circulation due to dilution effects. For example, poly(caprolactone)-b-poly(ethylene oxide) 
and poly(D,L-lactide)-b-methoxypolyethylene glycol micelles were found to dissociate within 
one hour under biological conditions.15, 16 Similar to the polymeric micelle, it is highly plausible 
that polymeric vesicles, termed polymersomes, would also quickly dissociate in circulation 
before achieving an effective accumulation in target tissues. To resolve this challenge, we 
hypothesized that reducing the bilayer permeability of polymersomes would greatly enhance the 
particle structural stability in circulation. Accordingly, the particles with a reduced permeability 
would enhance the quality of image-based diagnosis of pathologic tissues. 
We examined this hypothesis by introducing a controlled number of methacrylate groups 
into the bilayer of polymersomes formed from the self-assembly of poly(2-hydroxyethyl-co- 
octadecyl aspartamide) (PHEA-C18), because methacrylate groups can associate with each other 
and increase the packing density of the bilayer (Figure 2.1). In addition, after particle assembly, 
the methacrylate groups were cross-linked to further decrease the bilayer permeability.  
9 
Afterward, the polymer was further modified with a NIR fluorescent probe, FPR-675, and the 
capability of the resulting polymersome in detecting and imaging pathologic tissues was 
evaluated by systemically injecting them into a mouse tumor model of squamous cell 
carcinoma.8, 17 In summary, this study should greatly serve to expand the lifetime of 
polymersomes under physiological conditions, contribute to the early detection of pathologic 
tissues, and hence take image-based diagnostics to the next level. 
 
2.2 Results 
2.2.1 Preparation and characterizations of PHEA-C18 and PHEA-C18-MA 
Poly(2-hydroxyethyl-co-2-methacryloxyethyl-co-octadecyl aspartamide) (PHEA-C18-MA) 
was synthesized by modifying polysuccinimide (PSI) with octadecyl chains and methacrylate 
groups. PSI was prepared via the acid-catalyzed polycondensation of L-aspartic acid.18 The 
successive reactions of PSI with the designated amounts of octadecylamine and 2-aminoethyl 
methacrylate hydrochloride resulted in PSI substituted with octadecyl and methacrylate groups 
(Figure 2.2, PSI-C18-MA). Subsequent addition of an excess of ethanolamine to the polymer 
solution led to the substitution of all remaining succiminide units with hydroxyl groups (Figure 
2.2, PHEA-C18-MA), as confirmed with 1H NMR (Figure 2.3). Separately, PHEA-C18-MA 
without methacrylate groups (PHEA-C18) and unalkylated poly(2-hydroxyethyl aspartamide) 
(PHEA) were synthesized as control polymers. 
The degree of substitution of octadecyl chains (DSC18) of PHEA-C18 and PHEA-C18-MA 
polymers, defined as the mole percent of succinimide units substituted with octadecyl chains, 
was tuned to the range of 36 to 37 mol% according to the integrals of the characteristic NMR 
peaks at 0.85 to 0.95 ppm and 4.3 to 4.7 ppm (Figure 2.3 & Table 2.1). The peak at 0.85 to 0.95 
ppm represents the protons of methyl groups at the ends of the substituted octadecyl chains, and 
10 
the peak at 4.3 to 4.7 ppm is due to the protons on the polymer backbone. Additionally, the 
degree of substitution of methacrylate (DSMA) of PHEA-C18-MA, defined as the mole percent of 
succinimide units reacted with 2-aminoethy methacrylate hydrochloride, was tuned to 2.7 and 
4.8 mol%, as quantified by the integrals of the characteristic NMR peaks at 4.3 to 4.7, 5.7, and 
6.1 ppm. The peaks at 5.7 and 6.1 ppm represent the two protons on the vinyl carbon of the 
substituted methacrylate, and the peak at 4.3 to 4.7 ppm represents the protons on the polymer 
backbone (Figure 2.3). For convenience, PHEA-C18 and PHEA-C18-MA polymers at DSMA of 
2.7 and 4.8 mol% are termed as MA-0.0, MA-2.7, and MA-4.8, respectively. 
The ability of MA-0.0, MA-2.7, and MA-4.8 to self-associate in aqueous media was 
analyzed by the emission intensity of pyrene incorporated into the hydrophobic domain of the 
polymeric assembly. It is common to assess the critical aggregation concentration (CAC) of 
amphiphilic molecules by measuring the increase in the pyrene emission intensity ratio (I3/I1) 
between 385 (I3) and 373 (I1) nm.19 Pyrene mixed with unalkylated PHEA, formed by PSI 
substituted solely with hydroxyl groups, showed an insignificant increase in I3/I1 with the 
increasing polymer concentration, while the pyrene incorporated into a suspension of MA-0.0 
showed an increase of I3/I1 at a CAC of 5×10-2 mg/ml (Figure 2.4a). Furthermore, the CAC 
value was found to be inversely related to DSMA of the studied polymer (Figure 2.4b).  
2.2.2 Preparation and analysis of PHEA-C18 and PHEA-C18-MA polymersomes 
PHEA-based polymersomes were prepared by a solvent exchange process (Figure 2.5).  
Irgacure 2959 and polymers were first dissolved in dimethyl sulfoxide (DMSO) to provide chain 
mobility sufficient for intermolecular self-assembly in aqueous media. The subsequent 
introduction of this mixture into deionized water and the removal of DMSO by dialysis resulted 
in spherical polymersomes, as confirmed with transmission electron microscopy (TEM). The 
polymersome suspension was further exposed to ultraviolet (UV) light to activate the 
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cross-linking reaction within the bilayer of the polymersome. No significant difference of the 
particle morphology was found between the polymersome before (Figure 2.6a) and after 
(Figure 2.6b) the exposure to UV light.  
The average radii of MA-0.0, MA-2.7, and MA-4.8 polymersomes were also measured with 
dynamic light scattering (DLS) (Table 2.1). No significant difference in the average 
hydrodynamic radius (RH) was found between MA-0.0 or MA-2.7 polymersomes with or without 
a cross-linked bilayer. However, increasing the DSMA from 2.7 mol% to 4.8 mol% resulted in a 
decrease of RH from 102 to 90 nm and from 99 to 85 nm for the polymersome without 
cross-linked bilayers and those with, respectively.   
We further analyzed how the DSMA and the subsequent cross-linking reaction influenced the 
bilayer permeability of polymersomes by measuring the amount of calcein released from the 
polymersome during the incubation in deionized water or 10 % (v/v) plasma solution. Calcein is 
a fluorescein derivative that self-quenches as its concentration exceeds 2-3 mM.20 Therefore, 
encapsulated calcein at high concentrations self-quenches within polymersomes, while that 
released into the media generates fluorescence emission.21-22 As such, the suspension of 
polymersomes with the lower bilayer permeability should show a slower recovery of calcein 
fluorescence than those with the higher bilayer permeability. As expected, MA-2.7 polymersome 
with the cross-linked bilayer showed a smaller increase of fluorescent intensity than MA-2.7 
polymersome without the cross-linked bilayers, especially when the particles were incubated in 
10 % (v/v) plasma aqueous solution (Figure 2.6c). In addition, increasing the DSMA from 2.7 to 
4.8 mol% significantly limited the fluorescence recovery both in deionized water and in the 10 % 
plasma solution, even without cross-linking the bilayer. Interestingly, at the high DSMA, chemical 
cross-linking of the bilayer did not make a difference in the fluorescence recovery rate (Figure 
2.6c). 
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Biochemical stability of PHEA-based polymersomes was evaluated by monitoring changes 
of the particle radius while the polymersomes were incubated in PBS at 37 oC. MA-2.7 and 
MA-4.8 polymersomes displayed the better stability than MA-0.0 polymersomes, even without 
cross-linking the bilayer. The MA-0.0 polymersomes in PBS disappeared within 48 hours, 
following a two-fold increase of the average RH (Figure 2.7a). In contrast, MA-2.7 and MA-4.8 
polymersomes without cross-linked bilayers retained their original size over 12 days (open 
squares in Figure 2.7b & 2.7c). Interestingly, increasing DSMA significantly lessened the growth 
of RH over time. Specifically, the RH of MA-2.7 polymersomes increased from 108 to 214 nm 
within one day, followed by a gradual increase to 230 nm over the following 11 days (open 
squares in Figure 2.7b). In contrast, the RH of MA-4.8 polymersomes increased from 89 to 121 
nm in the first day, followed by a minimal increase of RH over time (open squares in Figure 
2.7c). 
Further cross-linking of the polymersome bilayer reduced the degree of increase in RH, 
depending on DSMA.  The RH of MA-2.7 polymersome with a cross-linked bilayer exhibited an 
increase from 100 to 200 nm within the first 24 hours and remained constant over the following 
11 days (filled squares in Figure 2.7b), which showed a lessened expansion than the RH of the 
MA-2.7 polymersome without a cross-linked bilayer.  In contrast, there was a minimal 
difference of the size change profile between the MA-4.8 polymersome with a cross-linked 
bilayer and that without a cross-linked bilayer (Figure 2.7c).   
Incubating polymersomes at 90 °C, which is above the melting temperature of the polymer 
(Figure 2.8), has also demonstrated different structural disintegration rates between the particles 
with a cross-linked bilayer and those without. The MA-0.0 polymersome disappeared within one 
day (Figure 2.9a). In contrast, both MA-2.7 and MA-4.8 polymersomes with cross-linked 
bilayers showed limited size changes (Figure 2.9b & 2.9c), while MA-4.8 polymersome with a 
13 
cross-linked bilayer had the slightest change on its size distribution before and after being 
incubated at the evaluated temperature. Additionally, these polymersomes demonstrated little, if 
any, cellular toxicity according to an analysis of cellular metabolic activity using MTT reagent. 
Endothelial cells incubated with 0.25 mg/ml or 0.01 mg/ml of MA-2.7 or MA-4.8 polymersomes 
retained a level of metabolic activity similar to untreated cells (Figure 2.10). 
2.2.3 Functionalization of polymersomes with a NIR fluorescent probe and in vivo 
assessment 
The polymersomes of MA-2.7 and MA-4.8 were functionalized with a NIR fluorescent 
probe, FPR-675, in order to use the particles as a tool to detect and image pathologic tissue 
innervated by abnormal, leaky vasculature. The sulfonic acid group of FPR-675 was conjugated 
to the hydroxyl group of PHEA-C18-MA via esterification (Figure 2.11). Accordingly, the 
polymersome suspension displayed an absorbance peak at 675 nm (Figure 2.12a), as well as 
NIR fluorescence emission at 700 nm upon excitation at 675 nm (Figure 2.12b).  
Next, the ability of FPR-675-labeled PHEA-C18-MA polymersomes to image tumor tissue 
was evaluated by systemically injecting them into circulation of a tumor-bearing mouse model 
and imaging the whole body with a real-time NIR fluorescence imaging system. The tumor was 
created by subcutaneously injecting squamous cell carcinoma (SCC7) into the back of a mouse. 
Injection of free FPR-675 solution via tail vein yielded a low level of positive fluorescence in 
tumor sites throughout 48 hours. The fluorescence intensity from the tumor site was comparable 
to the auto-fluorescence level of the neighboring tissue, thus making it difficult to distinguish 
tumor from the normal tissue (Figure 2.13a-I).   
In contrast, FPR-675-labeled MA-2.7 polymersome without a cross-linked bilayer made a 
1.4-fold increase of the fluorescent intensity compared to the free FPR-675 solution (Figure 
2.13a & 2.13b). Although the fluorescence from the FPR-675-labeled MA-2.7 polymersome 
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without a cross-linked bilayer in the tumor site gradually decreased throughout 48 hours, it was 
kept at a higher level than that of a mouse injected with the free FPR-675 solution. In addition, 
the FRP-675-labeled MA-2.7 polymersome with a cross-linked bilayer generated 1.6 times 
higher fluorescent intensity at the tumor site than the MA-2.7 polymersome without 
cross-linking one hour after injection (Figure 2.13b). This represented the highest intensity 
among the three injections over 48 hours, making the tumor site clearly distinguished from the 
normal neighboring tissue (Figure 2.13a-III). However, further decreasing the permeability of 
the polymersome bilayer by increasing DSMA made minimal enhancements in elevating the 
fluorescence intensity in cancer sites over time (Figure 2.14). 
Bio-distribution of free FPR-675 and FPR-675-labeled polymersomes were evaluated with 
NIR fluorescence images of multiple organs including liver, lung, spleen, kidney, heart, and 
tumor, all of which were collected 48 hours after the injection. Similar to the real time imaging, 
the highest NIR fluorescence of the ex vivo tumor was achieved with FPR-675-labeled MA-2.7 
polymersome with a cross-linked bilayer (Figure 2.13c). Additionally, the difference in NIR 
fluorescence between the tumor tissue and other organs, with the exception of the kidney, was 
also largest with the FPR-675-labeled, bilayer cross-linked MA-2.7 polymersome. Interestingly, 
absence of the cross-linked structure in the polymersome bilayer caused the particles to 
accumulate more in the kidney than in tumor tissue. 
 
2.3 Discussion 
In summary, this study demonstrates an advanced method to improve the imaging of 
pathologic, tumor tissue using PHEA-C18-MA polymersomes engineered to present less 
permeable bilayers. The bilayer permeability was decreased by introducing more numbers of 
methacrylate groups into the bilayer of the polymersome without cross-linking treatment, and 
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also by further cross-linking the bilayer. We found that the polymersome with a larger DSMA 
(MA-4.8 polymersome) was more stable in physiological media than that without methacrylate 
groups (MA-0.0 polymersome) and that with a smaller DSMA (MA-2.7 polymersome), even 
without cross-linking treatment. Additionally, the cross-linking of the bilayer further decreased 
the permeability and enhanced the stability of the polymersome compared to its uncross-linked 
form, but only for the MA-2.7 polymersome. Lastly, the MA-2.7 polymersome that was 
modified to carry a NIR fluorescent probe and present a cross-linked bilayer significantly 
improved the imaging quality of tumor sites over 48 hours after systemic injection. 
According to previous studies, polymersomes should disassemble more slowly than 
liposomes of a similar CAC when the concentration falls below the CAC.23-25 However, the 
complete disappearance of PHEA-C18 polymersomes in PBS within 48 hours implies that 
increasing the molecular weight of self-assembling molecules does not perfectly circumvent the 
structural disassembly on a long-term basis. We propose that methacrylate groups linked to the 
PHEA-C18 polymer backbone hydrophobically associate with each other in the confined bilayer 
together with octadecyl chains, due to the mismatch of Hildebrand solubility parameter between 
ethyl methacrylate (8.61 (cal/cm3)1/2)26 and water (23.5 (cal/cm3)1/2)27. Additionally, it is unlikely 
that these methacrylate groups impairs the vesicular structure of PHEA-C18-MA, as confirmed 
with TEM micrographs and supported by the theoretical calculation (Table 2.2).28-30 We suggest 
that both the hydrophobic association and the pH-independent cross-linking bonds between 
methacrylate groups greatly serve to improve particle stability and subsequent targeted imaging 
quality, whereas other cross-linking bonds such as hydrazine and disulfide bonds may 
disintegrate in tissue with pH deviating from neutral. Therefore, methacrylate groups 
incorporated into the bilayer likely played a similar role as cholesterol in phospholipid liposome 
bilayers. It is well agreed that cholesterol reduces the free space in bilayers,31, 32 and 
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subsequently enhances liposome stability.33 Similarly, increasing the packing density should 
decrease the bilayer permeability and further decelerate the structural disintegration of 
polymersomes caused by dilution effects, as manifested with the slower calcein release from 
MA-4.8 than MA-2.7 polymersomes without cross-linking and the smallest size increase of 
MA-4.8 polymersomes. We therefore interpret that the stability achieved by increasing DSMA is 
due to the increase of packing density in the bilayer. Additionally, the decrease of RH with 
increasing DSMA should be attributed to an increase of the hydrophobic association between 
polymers and the subsequent formation of a more compact bilayer. 
Additionally, cross-linking of the bilayer has further enhanced the MA-2.7 polymersome 
stability exclusively. The slower recovery of fluorescence from calcein in the MA-2.7 
polymersome with a cross-linked bilayer can be attributed to the decreased bilayer permeability, 
while the limited size increase of MA-2.7 polymersomes with a cross-linked bilayer over time 
indicates that the particle has a greater resistance to structural disintegration. In contrast, the 
independence of the bilayer permeability and particle size change on the cross-linking of the 
MA-4.8 polymersome bilayer is likely due to the high packing density of the bilayer negating the 
effect of cross-linking.  
Taken together, we propose that the control of bilayer permeability and particle stability 
serve to improve the quality of NIR fluorescence imaging of cancerous tissues. Prior studies on 
the EPR effect suggested that particle diameter should be smaller than 400 nm.34, 35 The size of 
PHEA-C18-MA polymersomes used in this study fit within this particle size range. However, it is 
likely that lipids in blood serum accelerate the expansion or disassembly of MA-2.7 
polymersomes without cross-linked bilayers,15, 16, 36 thus limiting the accumulation of particles in 
the tumor site via the EPR effect as well as accelerating the renal clearance of disassembled 
monomers due to the low molecular weight.37 Additionally, the accumulated particles in the 
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tumor site can be degraded gradually and hence the fluorescence of the area of interest decreased. 
In contrast, the MA-2.7 polymersome with a cross-linked bilayer should remain stable in 
circulation over an extended time period to extravasate through leaky tumor vasculature, and the 
accumulated particles in the tumor site, while still degradable, were degraded slower than the 
polymersome without cross-linked bilayers.   
Previously, some studies demonstrated that cross-linking the bilayer of a micro-sized 
gigantic polymersome results in increasing the surface elastic modulus, wall stress, and 
resistance to surfactant-induced disassembly than traditional liposomes.38, 39 However, no efforts 
have been made to improve detection and imaging of cancer tissue by translating these findings 
into the assembly of nano-sized polymersomes to date. Therefore, we envisage that our finding 
will be very useful to designing nanoparticles used for diagnostics and also treatment of various 
acute and malignant diseases, including cancer and cardiovascular diseases.40, 41 Further 
extending the lifetime of polymersomes in circulation, as well as the time window for cancer 
imaging with a single dose, could potentially be achieved by conjugating PEG chains to the 
PHEA-C18-MA polymersome. The quality of image-guided diagnostics will be further improved 
by conjugating peptides or antibodies that can specifically bind with target cells to the 
polymersomes developed in this study. On a separate note, though PHEA-C18-MA 
polymersomes have been shown to demonstrate limited toxicity to the mouse endothelial cells, 
further investigation is needed to evaluate performance in humans. 
 
2.4 Conclusion 
In summary, this study demonstrated a nanoparticle platform engineered to present a 
reduced permeability which is useful for significantly improving the detection and imaging of 
pathologic tissue. The methacrylate groups attached to a self-assembling polyaspartamide 
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polymer served to reduce the bilayer permeability, likely because they associated with other 
hydrophobic alkyl chains and increased the packing density. Cross-linking of the methacylate 
groups post-assembly of the nanoparticles further reduced the bilayer permeability, thus leading 
to another increase of the particle stability in physiological media, exclusively at intermediate 
degree of substitution for methacrylate groups to the polymer. Therefore, the polymersome 
conjugated with a NIR fluorescent probe and also tailored to display the reduced permeability 
significantly improved the imaging quality of tumor sites over 48 hours after systemic injection.  
These results certify the importance of extending the lifetime of nanoparticles in improving their 
function in detecting and imaging pathologic tissues of interest. Finally, the polymersomes with 
a tailored permeability will be useful in future studies to modulate the release rate of various 
therapeutic molecules and ultimately improve the quality of diagnosis and treatment of diverse 
diseases. 
 
2.5 Experimental Section 
Materials were purchased from Sigma-Aldrich (USA) and used without further purification 
unless otherwise specified. 
2.5.1 Synthesis of poly(2-hydroxyethyl-co-octadecyl aspartamide) (PHEA-C18) and 
poly(2-hydroxyethyl-co-2-methacryloxyethyl-co-octadecyl aspartamide) (PHEA-C18-MA) 
Polysuccinimide (PSI) was synthesized by thermal condensation of L-aspartic acid (30 g) 
suspended in sulfolane (150 ml) at 170°C under a nitrogen atmosphere for 14 hours with 
phosphoric acid (0.612 mL, Fisher Scientific) as a catalyst.18 PSI was precipitated in excess 
methanol and successively washed with deionized water until the pH of the suspension reached 
neutral. The precipitate was dried by lyophilization. The molecular weight of PSI was 
determined by gel permeation chromatography (Breeze 2 GPC, Waters), with Styragel® HT 
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column (Waters). N,N-dimethylformamide (DMF) containing 20 mM LiBr was used as the 
eluent, with the elution rate of 1 mL min-1. Polystyrene standards were used for calibration. Mn = 
13,600 g mol-1 with PDI = 1.4. 
Purified PSI (79 mg) was dissolved in DMF (5 ml, Fisher Scientific), and octadecylamine 
(79 mg for MA-0.0, MA-2.7, and MA-4.8, respectively) was added to the reaction mixture. The 
reaction was stirred at 70 °C for 24 hours. Next, a designated amount of 2-aminoethyl 
methacrylate hydrochloride (AEMA) (0 µL for MA-0.0, 195 µL for MA-2.7, and 391 µL for 
MA-4.8) and triethylamine (TEA, Fisher Scientific) (0 µL for MA-0.0, 10.6 µL for MA-2.7, and 
21.2 µL for MA-4.8) were added to the reaction mixture, and the solution was stirred at 45 °C for 
24 hours. The molar ratio of AEMA to TEA was 1:3. Lastly, an excess amount of ethanolamine 
was added (96.8 µL for MA-0.0, 82.3 µL for MA-2.7, and 75.4 µL for MA-4.8) and the reaction 
was further stirred at 45 °C overnight. Following completion of the chemical reactions, the 
products were dialyzed (MWCO 3500 Da, Fisher Scientific) extensively in deionized water at 
room temperature for two days and then lyophilized to yield dry powders.   
2.5.2 Characterization of PHEA-C18 and PHEA-C18-MA polymers 
1H NMR (Varian Unity 500 MHz) was applied to analyze the polymer dissolved in 
DMSO-d6 (Cambridge Isotope Laboratories, Inc.). The integrals of characteristic peaks were 
used to quantify the degree of substitution of octadecyl chains (DSC18) and the degree of 
substitution of methacrylate groups (DSMA) in each sample by Eq. (1) and (2): 
 (mol%) =        . .  ! "⁄      $."$.% ! × 100 %  ....................................... (1) 
)*  (mol%) =   +,!   +     .% ! -  .. ! /⁄      $."$.% ! × 100 %  ............ (2) 
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2.5.3 Measurement of the critical aggregation concentration (CAC)  
Pyrene molecules (Acros) were suspended in the polymer solution at a concentration of 10-4 
mg ml-1. The fluorescent spectra of the suspensions with varying polymer concentrations were 
collected using a FluoroMax®-4 spectrometer (HORIBA Jobin Yvon). The excitation wavelength 
was set at 330 nm and the resulting emission between 350 and 450 nm was collected; the slit 
widths for excitation and emission were both set as 1 nm. The CAC was determined by the 
polymer concentration at the point where the emission intensity ratio (I3/I1) between the third 
vibronic peak at 385 nm (I3) and the first vibronic peak at 373 nm (I1) was significantly 
increased.19 
2.5.4 Synthesis of PHEA-C18-MA labeled with FPR-675   
5 µmol FPR-675 (BioActs) was dissolved in 500 µl of DMSO (Merck) and added dropwise 
to PHEA-C18-MA dissolved in DMSO (10 mg in 2 mL). The reaction mixture was stirred 
overnight at room temperature in the dark. The products were dialyzed extensively in deionized 
water with light protection at room temperature to remove the free dye and DMSO, and then 
lyophilized to yield dry powders. The resulting polymers were analyzed with a UV/Vis 
spectrophotometer Lambda 7 (Perkin-Elmer).  
2.5.5 Preparations of PHEA-C18 and PHEA-C18-MA polymersomes 
PHEA-C18-MA polymers and Irgacure 2959 (Ciba Specialty Chemicals) were dissolved in 
DMSO at a concentration 10 and 100 mg mL-1, respectively. 100 µL polymer in DMSO was 
mixed with 20 µL initiator in DMSO, and the mixture was dropped into 1 mL deionized water.  
The solution was sonicated for 10-15 seconds and then dialyzed in deionized water extensively 
to remove DMSO and excess initiator overnight. During dialysis, the suspension was covered 
with aluminum foil to prevent exposure to light. The purified suspension was finally exposed to 
UV light (Model 20 CHIPhERASER, Jelight Co. Inc.) for 5 min to cross-link the bilayer of the 
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polymersome. Separately, in preparation of PHEA-C18 or PHEA-C18-MA polymersomes without 
cross-linked bilayers, Irgacure 2959 was not mixed with the polymer solution; nor was the 
polymersome suspension exposed to UV light.  n the stability analysis, 10× phosphate buffered 
saline (PBS) was added to adjust the ionic strength of the polymersome suspension to 1× PBS 
after the particle preparation. 
2.5.6 Cytotoxicity evaluation of PHEA-C18-MA polymersomes 
C166 mouse endothelial cells (ATCC) were seeded on a 96-well plate at 104 cells per well. 
Cells were incubated for 24 hours with MA-2.7 polymersomes or with MA-4.8 polymersomes. 
MTT reagent ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, ATCC) was then 
added to the cell culture media. Metabolically active cells convert the MTT reagent to formazan 
dye, which can be quantified by measuring its absorbance at 570 nm (Tecan Infinite 200 PRO, 
Tecan AG). Cellular metabolic activity is presented as a percent of a control, i.e. cells cultured 
without the presence of polymersome. Error bars are shown as the standard deviation of three 
replicates. 
2.5.7 Characterization of PHEA-C18 and PHEA-C18-MA polymersomes 
The morphology of self-assembled PHEA-C18-MA polymersomes was observed using TEM 
(JEOL 2100 with LaB6 emitter) operating at an accelerating voltage of 120 keV. The 
polymersome suspension was dropped onto a 300-mesh copper grid coated with carbon and 
formvar (SPI Supplies), and the sample was stained with 2 % (w/v) phosphotungstic acid 
solution (adjusted to pH 7.4 with NaOH). The size of PHEA-C18-MA polymersomes was 
measured using Malvern Zetasizer Nano ZS (Malvern, 4 mW He-Ne laser operating at a 
wavelength of 633 nm) with 173° backscattering. The hydrodynamic radius was determined 
using Cumulant analysis (International Organization for Standardization 13321:1996). All 
measurements were carried out in triplicate and performed at 25°C.  
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2.5.8 Calcein release study  
PHEA-C18-MA polymersomes were prepared by the solvent exchange process. Then, 50 
mM calcein (Fisher Scientific) aqueous solution was added slowly into the polymersome 
suspension to a final concentration of 25 mM for diffusional loading. The suspension was 
incubated at room temperature with stirring for one day for calcein to reach equilibrium, and 
exposed to UV light to activate the cross-linking reaction in the bilayer of polymersomes. 
Certain polymersome suspensions were not exposed to UV light for a control experiment. The 
excess calcein which was not incorporated into the polymersomes was removed by Amicon ® 
Ultra-0.5 Centrifugal Filter Devices (MWCO 100k Da, Millipore Corporation). The 
polymersomes were incubated within deionized water or deionized water supplemented by 10 % 
(v/v) human plasma (Equitech-Bio Inc.). After incubation for 30 minutes at room temperature, 
the amount of calcein released from the polymersome was measured with the emission intensity 
at 535 (± 20) nm at the excitation of 485 (± 20) nm using a microplate reader (Infinite 200Pro, 
Tecan Group Ltd.). 
2.5.9 In vivo non-invasive NIR fluorescence imaging of polymersomes in tumor-bearing 
mice 
All animal experiments were performed in compliance with the guidelines approved by the 
institutional ethics committee for animal care of Korea Institute of Science and Technology 
(KIST). To generate a tumor-bearing mice model, squamous cell carcinoma (SCC7) tumors were 
induced into 5-week-old male athymic nude mice (Institute of Medical Science, Tokyo) by 
subcutaneous injection of 1.0×106 SCC7 cells. When the tumor diameter grew to approximately 
10 mm, the test samples (5 mg kg-1) were injected into the tumor-bearing mice through the tail 
vein, and the whole body images were taken at 1, 3, 6, 12, 24, and 48 hours after the injection, 
using a time-domain fluorescence imager eXplore Optix (ART Advanced Research Technologies 
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Inc.). Laser power and count time settings were optimized at 9 µW and 0.3 second per point. 
Excitation and emission spots were raster-scanned in 1 mm steps over the selected region of 
interest to generate emission wavelength scans. A 675 nm pulsed laser diode was used to excite 
FPR-675 molecules. NIR fluorescence emission at 700 nm was collected and detected with a fast 
photomultiplier tube (Hamamatsu) and a time-correlated single photon counting system (Becker 
and Hickl GmbH). NIR fluorescence intensities of all samples were adjusted to the same values 
based on the data obtained by a 12-bit CCD camera (Kodak Imaging Station 4000 MM, New 
Haven) equipped with a special C-mount lens and a Cy5.5 bandpass emission filter set (680 to 
720 nm, Omega Optical). Furthermore, the accumulation level of samples in the tumors was 
evaluated by measuring the NIR fluorescence intensity at the cancer site. All data were processed 
using the region of interest (ROI) function of the Analysis Workstation software (ART 
Advanced Research Technologies Inc.). 
2.5.10 Ex vivo organ analysis 
After intravenous injection of FPR-675 labeled polymersomes, major organs and tumors 
were dissected from mice 48 hours after the injection. NIR fluorescence images of dissected 
organs including liver, lung, spleen, kidney, heart and tumors were obtained with Kodak Image 
Station 4000 MM. The image station was equipped with a 12-bit CCD camera, halogen lamp 
(150 W), and excitation/emission filter sets for FPR-675 (600-700 nm; Omega Optical). The 
biodistribution of polymersomes was evaluated by quantifying the NIR fluorescence intensity of 
the organ and tumor images processed with Kodak molecular imaging software. 
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Figure 2.2. Synthesis of PHEA-C18-MA, where the polymer backbone was substituted with 
octadecyl chains and a varying degree of substitution of methacrylate (DSMA, denoted as ‘z’ in the 
scheme; z = 0 for PHEA-C18). ‘x’ and ‘y’ in the reaction scheme represent the degree of 
substitution of hydroxyl groups and the degree of substitution of octadecyl chains (DSC18), 
respectively.  
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Figure 2.3. 1H NMR (DMSO-d6, 500 MHz) spectra of (a) PHEA-C18 without methacrylate 
groups (MA-0.0), (b) PHEA-C18-MA at DSMA of 2.7 mol% (MA-2.7), and (c) PHEA-C18-MA at 
DSMA of 4.8 mol% (MA-4.8).  
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Figure 2.4. Pyrene-based fluorescence analysis of polyaspartamide polymersomes. (a) The 
fluorescence spectrum while the pyrene was incorporated into a suspension of MA-0.0, MA-2.7, 
MA-4.8, and PHEA in phosphate buffered saline (PBS), respectively. (b) The critical 
aggregation concentration (CAC), marked by the turning point of I3/I1 values in (a), of MA-0.0, 
MA-2.7, and MA-4.8 in PBS.  
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Figure 2.5. Schematic description of the solvent exchange process to prepare PHEA-C18-MA 
polymersomes with cross-linked bilayers.  
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Figure 2.6. Morphology characterization and bilayer permeability analysis of 
polyaspartamide polymersomes. (a) TEM micrographs of the self-assembled polymersomes of 
(I) MA-0.0, (II) MA-2.7, and (III) MA-4.8, all of which the bilayers were not cross-linked. (b) 
TEM micrographs of the self-assembled polymersomes of (I) MA-2.7 and (II) MA-4.8 The 
bilayers of MA-2.7 and MA-4.8 polymersomes were cross-linked. All the scale bar in (a) and (b) 
represent 200 nm. (c) Calcein-based fluorescence analysis of MA-2.7 and MA-4.8 polymersomes, 
either with cross-linked (CL) or without cross-linked (NCL) bilayers. The filled and open bars 
represent polymersomes incubated in deionized water and in deionized water supplemented with 
plasma (10 %, v/v), respectively. 
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Figure 2.7. Stability analysis of polyaspartamide polymersomes with dynamic light 
scattering (DLS). The changes in the hydrodynamic radius (RH) of the polymersomes of (a) 
MA-0.0, (b) MA-2.7, and (c) MA-4.8. The polymersomes were incubated in PBS at 37 °C. The 
filled and open squares represent the polymersomes with bilayers in which methacrylate groups 
were cross-linked and not cross-linked, respectively. *After two days, RH of MA-0.0 
polymersomes could not be measured with DLS. 
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Figure 2.8. Differential scanning calorimetry (DSC) thermogram of PHEA and PHEA-C18.  
DSC measurements were performed under a nitrogen atmosphere at a heating rate of 10 °C/min 
using Perkin Elmer Diamond DSC, and the heat flow of the polymer during the heating process 
was measured. 
 
 
Figure 2.9. Effects of DSMA on the size distribution of the polymersomes of (a) MA-0.0, (b) 
MA-2.7, and (c) MA-4.8. Bilayers of MA-2.7 and MA-4.8 polymersomes were cross-linked.  
The filled and open circles represent the polymersomes suspended in PBS before and after 
incubation at 90 °C for 24 h, respectively. *The majority of MA-0.0 polymersomes disappeared 
after incubation at 90 °C. 
0 20 40 60 80 100
PHEA-C18
He
a
t F
lo
w
 
En
do
 
Up
Temperature (oC)
PHEA
Tm
(a) (b) (c)
*
0 200 400
0
10
65
70
In
te
n
si
ty
 
(%
)
Radius (nm)
0 200 4000
5
10
15
In
te
n
si
ty
 
(%
)
Radius (nm)
0 200 4000
5
10
15
In
te
n
si
ty
 
(%
)
Radius (nm)
37 
 
Figure 2.10. Cellular metabolic activity of C166 mouse endothelial cells analyzed with an MTT 
reagent. 
 
 
Figure 2.11. PHEA-C18-MA functionalized with a near-infrared (NIR) fluorescent probe, 
FPR-675.  
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Figure 2.12. Characterization of PHEA-C18-MA polymersomes modified with the NIR 
probe, FPR-675. (a) UV-visible spectrum of MA-2.7 conjugated with FPR-675. (b) The NIR 
fluorescence image of (I) free FPR-675 solution, (II) FPR-675-labeled MA-2.7 polymersome 
suspension, and (III) FPR-675-labeled MA-4.8 polymersome suspension. The methacrylate 
groups in the bilayers of polymersomes were cross-linked. 
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Figure 2.13. In vivo evaluation of PHEA-C18-MA polymersomes in targeting and imaging 
tumors. (a) NIR fluorescence images of tumor-bearing mice after the intravenous injection of (I) 
free FPR-675 probes, (II) FPR-675-labeled MA-2.7 polymersomes without cross-linked bilayers, 
and (III) FPR-675-labeled MA-2.7 polymersomes with cross-linked bilayers. Arrows mark the 
tumor site. (b) NIR fluorescent intensity changes over 48 hours in the tumor tissues of the 
corresponding mouse shown in (a). ( ) represents free FPR-675 dye, ( ) represents 
FPR-675-labeled MA-2.7 polymersomes without cross-linked bilayers, and ( ) represents 
FPR-675-labeled MA-2.7 polymersomes with cross-linked bilayers. (c) NIR fluorescence 
intensities of the ex vivo organ images from the tumor-bearing mice 48 hours after the injection. 
The black, red, and blue bars represent free FPR-675 dye, FPR-675-labeled MA-2.7 
polymersomes without cross-linked bilayers, and FPR-675-labeled MA-2.7 polymersomes with 
cross-linked bilayers, respectively.   
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2.8 Tables 
Table 2.1. Molecular analysis of PHEA-C18 and PHEA-C18-MA with controlled DSMA. 
Sample DSC18 [mol%]a) DSMA [mol%]a) 
Hydrodynamic radius 
(RH, nm)b) 
Not cross-linked Cross-linked 
MA-0.0 36.7 0.0 102 ± 2 - 
MA-2.7 36.4 2.7 102 ± 8 99 ± 3 
MA-4.8 36.9 4.8 90 ± 5 85 ± 5 
a)
 Determined with the 1H NMR spectra of the polymers; b) Determined by dynamic light 
scattering (DLS).  The particles were suspended in deionized water.  Data represented are the 
average values followed by the standard deviation from three independent experiments. 
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Table 2.2. Molecular analysis of PHEA-C18 and PHEA-C18-MA with controlled DSMA. 
Sample 
DSC18 
[mol%]a) 
DSMA 
[mol%]a) 
mass percentage of 
the hydrophilic 
grafting to the total 
macromoleculueb) 
Morphologyc) 
MA-0.0 36.7 0.0 44.1 polymersome 
MA-2.7 36.4 2.7 42.2 polymersome 
MA-4.8 36.9 4.8 40.0 polymersome 
a)
 Determined with the 1H NMR spectra of the polymers; b) Calculated by 
(100 − DS − DS)*) × mass of PHEA unit substituted with a hydroxyl group
averaged unit molecular weight × 100% 
, where the average unit molecular weight is calculated by averaging the mass of the PHEA unit 
substituted with a hydroxyl group (174 g mol-1), substituted with a octadecyl group (381 g mol-1), 
and substituted with a methacrylate group (242 g mol-1) by the degree of substitution; c) The 
amphiphilic PHEA-C18 substituted with a mass percentage of the hydrophilic grafting to the total 
macromolecule in the range of 25-45 % have been shown to favor the polymersome formation in 
aqueous solution.345  
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Chapter 3 Bacterium-Mimicking Nanoparticle Surface Functionalization 
with Targeting Motifs 
3.1 Introduction 
Nanoparticles formed from intermolecular self-assembly, such as micelles and vesicles, 
have been extensively studied as carriers of various molecules used in a wide array of 
applications, including sensing,1, 2 bioimaging,3-5 and drug delivery.6, 7 Amphiphilic molecules 
constituted with hydrophobic and hydrophilic segments are being commonly used as a building 
block of the self-assembled nanoparticles, because of the association between hydrophobic 
segments in aqueous media.8 The size and the morphology of resulting nanoparticles are 
significantly dependent on the molecular weight and the packing parameter of amphiphilic 
molecules.9, 10   
These nanoparticle surfaces are often functionalized with varied bioactive molecules that 
can specifically bind with surfaces of interest, in order to deliver molecular cargos to a target site 
and subsequently elevate their desired performance. It is common to chemically conjugate 
targeting biomolecules to nanoparticles before or post the self-assembly.11 Alternatively, the 
nanoparticle surface and the targeting ligand are connected by conjugating biotin and avidin or 
streptavidin to each pair.11 These processes, however, require multi-step chemical modification 
and effortful purification, which inadvertently lead to a low production yield and a large 
production cost. Additionally chemical conjugation of targeting biomolecules to amphiphilic 
molecules prior to nanoparticle assembly can encounter loss of bioactivity of biomolecules as 
well as localization into the nanoparticle core. 
Apart from these conventional methods, a living organism offers a simple way to present a 
wide array of biomolecules on its surface. For example, the bacterium Staphylococcus aureus 
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expresses protein A (SpA), a surface protein that can bind with the heavy chain in the Fc-region 
of immunoglobulins.12 SpA associates with the membrane of Staphylococcus aureus and inhibits 
opsonophagocytosis by binding with the host antibody, so it aids the survival of the bacterium.13 
Inspired by this process, we hypothesized that insertion of alkylated SpA into the surface layer of 
a self-assembled nanoparticle will allow us to readily modify the nanoparticle surface with 
various antibodies of interest that can function as targeting motifs (Figure 3.1).14 We examined 
this hypothesis by using SpA modified with palmitic acid (SpA-PA) and directing 
self-association between SpA-PA and a micelle of poly(2-hydroxyethyl aspartamide) substituted 
with octadecyl chains, termed PHEA-g-C18. The micelle coupled with SpA-PA was coated by 
antibodies to vascular cell adhesion molecules-1 (VCAM-1) or integrin αvβ3 via simple mixing 
of pre-made micelle with antibodies. The biological association between the SpA-PA of the 
micelle and the antibody was monitored by analyzing the fluorescence resonance energy transfer 
(FRET) between SpA-PA and the antibody, each of which was labeled with FRET donor and 
acceptor, respectively. The targetability of resulting micelles toward a substrate coated with 
VCAM-1 or integrin αvβ3 was evaluated with surface plasmon resonance (SPR) spectroscopy 
and a blood vessel-mimicking flow chamber. Taken together, this study will greatly serve to 
advance the surface functionalization process via the bio-inspired modular self-assembly and 
potentially elevate the performance level of a wide array of nanoparticles. 
 
3.2 Results and Discussion 
3.2.1 Preparations and characterizations of PHEA-g-C18 micelles 
First, PHEA-g-C18 was synthesized through nucleophilic substitution of designated amounts 
of octadecylamine and excessive amount of ethanolamine to poly(succinimide) (PSI) (Figure 
3.2a), as characterized with the 1H NMR spectra (Figure 3.3). According to integrals of NMR 
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peaks at 0.85 to 0.95 ppm and 4.3 to 4.7 ppm, the degree of substitution for octadecyl chains 
(DSC18) to the polymer, defined as the mole percentage of succinimide units substituted with 
octadecyl chains, was varied from 2.4 to 6.4 and 14.8 mol % (Table 3.1). The peak at 0.85 to 
0.95 ppm in the NMR spectrum represents protons of methyl groups at the ends of the 
substituted octadecyl chains, and the peak at 4.3 to 4.7 ppm represents protons on the 
polyaspartamide backbone (Figure 3.3). For convenience, PHEA-g-C18 at DSC18 of 2.4, 6.4, and 
14.8 mol % were termed as DS-2.4, DS-6.4, and DS-14.8, respectively.   
Addition of PHEA-g-C18 into phosphate buffer saline (PBS) and subsequent sonication 
created polymeric micelles via in-situ self-assembly. Increasing DSC18 of PHEA-g-C18 has 
dramatically decreased the corresponding critical micelle concentration (CMC), which was 
marked by the significant increase in the emission intensity ratio (I3/I1) between 385 (I3) and 373 
(I1) nm of pyrene added in the aqueous micelle suspension15 (Table 3.1 & Figure 3.4). The 
z-average hydrodynamic radii of the micelles, measured with the dynamic light scattering (DLS) 
unit, became larger by increasing DSC18 of PHEA-g-C18 (Table 3.1). Micrographs acquired with 
the transmission electron microscope (TEM) confirmed the spherical morphology of 
PHEA-g-C18 micelles (Figure 3.2b). The zeta-potential of micelles were in the range of -10 to 
-12 mV independent of DSC18 (Figure 3.2c). 
3.2.2 Surface modification of PHEA-g-C18 micelles with palmitic acid-conjugated 
Staphylococcus aureus protein A (SpA) 
Chemical reaction of palmitic acid N-hydroxysuccinimide ester with amine groups of SpA 
resulted in the SpA conjugated with palmitic acid, termed SpA-PA (Figure 3.5a-1). The 
resulting SpA-PA coupled with PHEA-g-C18 micelles via a simple mixing process at room 
temperature (Figure 3.5a-2), as monitored with the SpA-PA labeled with fluorescein. In contrast, 
the unmodified SpA-PA minimally associated with PHEA-g-C18 micelles (data not shown). The 
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percentage of SpA-PA associated with the polymeric micelles increased from 9 (± 0.5 %) to 38 
% (± 6 %) by increasing DSC18 of PHEA-g-C18 from 2.4 to 14.8 %, as quantified with the 
fluorescence intensity from the micelle following centrifugation-based purification (Figure 
3.5b).  
The underlying mechanism by which the palmitic acid enhanced the association of SpA-PA with 
the PHEA-g-C18 micelles was examined by quantifying changes in the Gibbs free energy (∆G), 
enthalpy (∆H), and entropy (∆S) of this self-assembly process. ∆G calculated using Eq. (1) 
became a more positive value at a given temperature (T) as DSC18 decreased from 14.8 to 2.4 mol 
% (Figure 3.5c). 
∆A = −BC lnDE Eq. (1) 
where DE = [)GG,- H*I*][K H*I*][)G+]   
Where R is the gas constant, [Micelle-coupled SpA-PA] is the concentration of SpA-PA 
associated with micelles, [Free SpA-PA] is the concentration of excess SpA-PA, and [Micelles] 
is the concentration of PHEA-g-C18 micelles. ∆H calculated from the slope of Van’t Hoff plot 
(Figure 3.5d based on Eq. (2)) was 11.4 kJ/mol for the DS-14.8 coupled with SpA-PA, while 
∆H for DS-2.4 was -6.3 kJ/mol (Figure 3.5e). In addition, ∆S calculated from the intercept of 
Van’t Hoff plot presented a larger, positive number for the association of SpA-PA with DS-14.8 
micelles than that with DS-2.4 micelles (Figure 3.5e).  
ln DE = L−ΔNB O (
1
C) +
Δ
B  
Eq. (2) 
These analytical results suggest that the association of SpA-PA with DS-2.4 was 
thermodynamically unfavorable, as characterized with the negative ∆S and the positive ∆G of the 
process. In contrast, increasing DSC18 led to thermodynamically favorable association between 
SpA-PA and DS-14.8 as confirmed with the positive ∆S and the negative ∆G. The positive ∆S of 
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the assembly of SpA-PA with DS-14.8 was likely due to the release of ions and water molecules 
from the insertion interface between SpA-PA and DS-14.8 micelle surface.4 In contrast, the 
negative ∆S of SpA-PA coupled with DS-2.4 is due to the entropic penalty of assembling 
SpA-PA-coupled DS-2.4 micelles was more, in magnitude, than the entropy increase resulting 
from the desolvation happened in the interface between SpA-PA and DS-2.4 micelle surface. In 
sum, decreasing DSC18 of PHEA-g-C18 lessened this desolvation effect and hence conferred the 
negative ∆S for SpA-PA-coupled DS-2.4 micelles. Additionally, the assembly of DS-2.4 with 
SpA-PA, driven by ∆H while penalized entropically, can be referred to as the “non-classical” 
hydrophobic effect.16-18  
3.2.3 FRET analysis of the assembly of antibody-coated PHEA-g-C18 micelles 
The PHEA-g-C18 micelle coated by antibodies to VCAM-1 and integrin αv was created by 
simply mixing the SpA-PA-coupled DS-2.4 or DS-14.8 micelles with antibodies at 4 °C for 60 
minutes. The FRET assay was conducted to confirm the binding between the antibody and 
SpA-PA on the micelle surface (Figure 3.6a). Interestingly, mixing of micelles coated by the 
fluorescein (i.e., FRET donor)-conjugated SpA-PA with the rhodamine (i.e., FRET 
acceptor)-conjugated VCAM-1 antibodies resulted in a significant decrease of the fluorescein 
emission intensity maximized at the wavelength of 520 nm and an increase of the rhodamine 
emission intensity maximized at the wavelength of 580 nm (Figure 3.6b). These results 
confirmed the specific association between SpA-PA and antibodies. The degree of FRET (DFRET) 
between the SpA-PA and the antibody was quantified with the emission intensity of fluorescein 
in the absence (Ifluorescein,0) and presence (Ifluorescein) of rhodamine-labeled antibody following Eq. 
(3):19 
KQR = 1 − ST,+GST,+G, 
Eq. (3) 
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Note that DFRET increases proportional to the number of antibodies bound to SpA-PA 
coupled on the micelle surface. During the incubation of antibodies with SpA-PA-coupled 
micelles in PBS, DFRET with DS-14.8 ones remained at approximately 0.9, while DFRET with 
DS-2.4 ones significantly decreased (Figure 3.6c). The reduced DFRET indicated the active 
separation of antibodies from the surface of SpA-PA-coupled DS-2.4 micelles. 
3.2.4 Analysis of the adhesion of antibody-coated PHEA-g-C18 micelles onto a target 
substrate 
The targeting capability of antibody-coated PHEA-g-C18 micelles was evaluated with a 
surface plasmon resonance (SPR) spectroscopy. VCAM-1 and integrin αvβ3 were chosen as the 
target proteins. It is well known that inflamed endothelium has higher levels of VCAM-1 and 
integrin αvβ3 expression than healthy endothelium.20, 21 The targeting efficiency of the 
antibody-coated SpA-PA-micelles was evaluated by measuring the binding response unit (RU) 
of the micelle with a model cell membrane, which was built by conjugating VCAM-1 or integrin 
αvβ3 to a monolayer of 11-mercaptoundecanoic acid (MUA) on the SPR chip (Figure 3.7a).  
RU after the injection (RUdisso) of SpA-PA-coupled DS-14.8 micelles coated by antibodies 
to VCAM-1 (solid line in Figure 3.7b-1) was 6-fold higher than that of SpA-PA-coupled 
DS-14.8 micelles free of antibodies (dashed line in Figure 3.7b-1) (Figure 3.7d-1). Note that the 
binding response of the sensogram represents the mass density of the micelles on the model cell 
membrane22 due to the association and dissociation of micelles. Likewise, RUdisso of 
SpA-PA-coupled DS-14.8 micelles coated by antibodies to integrin αv (solid line in Figure 
3.7b-2) was more than 2-fold higher than that of SpA-PA-coupled DS-14.8 micelles free of 
antibodies (dashed line in Figure 3.7b-2) (Figure 3.7d-1). In contrast, SpA-PA-coupled DS-2.4 
micelles coated by antibodies exhibited a relatively small increase in RUdisso compared with that 
of the SpA-PA-coupled DS-2.4 micelles free of antibodies, because of the smaller loading of 
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antibodies characterized with FRET analysis. RUdisso of SpA-PA-coupled DS-2.4 micelles coated 
by antibodies to VCAM-1 and integrin αv (solid line in Figure 3.7c) was only 3.3-fold and 
1.3-fold, respectively, higher than that of the antibody-free SpA-PA-coupled DS-14.8 micelles 
(dashed line in Figure 3.7c) (Figure 3.7d-2). For another control experiment, DS-14.8 micelles 
free of SpA-PA were mixed with antibodies to VCAM-1. RUdisso of the control was almost 
2-fold smaller than that of SpA-PA-coupled DS-14.8 micelles coated by antibodies (Figure 3.8).  
Finally, the targeted adhesion of SpA-PA-coupled DS-14.8 micelles coated by antibodies to 
integrin αv was evaluated by injecting them into a flow chamber that presented a substrate coated 
with integrin αvβ3 (Figure 3.9a).23 To simulate in vivo circulation, the average bulk flow 
velocity of the media was set as 1 mm/s. DS-14.8 polymers were labeled with rhodamine in 
order to locate SpA-PA-coupled DS-14.8 micelles bound to the substrate with a confocol 
microscope. The SpA-PA-coupled DS-14.8 micelles coated by antibodies adhered to the 
substrate more actively than ones without antibodies, as confirmed with a significantly larger 
fluorescence area (Figure 3.9b & 3.9c). In contrast, no significant difference was found between 
antibody-coated SpA-PA-coupled DS-14.8 micelles and antibody-free ones with a control 
substrate free of integrin αvβ3 (results not shown). 
Overall, this study demonstrates that SpA-PA can act as a linker to bridge antibodies of 
interest to PHEA-g-C18 micelle surfaces. It is suggested that SpA-PA bind with the Fc domain of 
the antibody without affecting specific interaction between antibodies and target proteins on 
surfaces. Previous studies have covalently conjugated SpA or protein G to the particle surface, 
and then incubated the particle with the antibody of interest to confer particles the specific 
targetablity.24, 25 Our modular coupling of alkylated SpA to micelles via thermodynamically 
driven self-assembly should be distinguished from previous approaches that should undergo 
multi-steps of chemical modification and purification. We envisage that such simple yet 
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elaborate antibody immobilization strategy would be useful to functionalize a wide array of 
nanoparticles assembled via self-assembly between lipids and amphiphilic copolymers.  
 
3.3 Conclusion 
In conclusion, this study successfully demonstrates that alkylated SpA (SpA-PA) act as a 
linker to immobilize antibodies of interest on PHEA-g-C18 micelle surfaces assembled in 
advance. The entropy-driven self-association between SpA-PA and micelles was tuned by 
increasing the number of alkyl chains (DSC18) conjugated to PHEA-g-C18. Thus, SpA-PA 
coupled with micelles assembled by PHEA-g-C18 with a higher DSC18 resulted in stable 
immobilization of antibodies on micelle surfaces, as confirmed with FRET analysis. The 
micelles functionalized with antibodies to VCAM-1 or integrin αv via this sequential, biological 
coupling displayed a larger binding affinity to target substrates than the micelles without 
antibodies. Likewise, under circulation-mimicking flow, the antibody-coated micelles adhered to 
the target substrate more favorably than the antibody-free ones. In sum, this simple yet elaborate 
bioinspired protein immobilization would be broadly useful to surface functionalization of 
nanoparticles with a wide array of proteins of interest. Ultimately, the results of this study will 
greatly serve to improve the quality of nanoparticles used in various applications including 
sensing, diagnosis, and clinical treatments. 
 
3.4 Experimental Section 
Materials were purchased from Sigma-Aldrich (USA) and used without further purification 
unless otherwise specified. 
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3.4.1 Synthesis of poly(2-hydroxyethyl-co-octadecyl aspartamide) (PHEA-g-C18) 
Poly(succinimide) (PSI) was synthesized by thermal condensation of L-aspartic acid 
suspended in sulfolane at 170°C under nitrogen atmosphere for 14 hours with the phosphoric 
acid (Fisher Scientific) as a catalyst.26 PSI was precipitated in excess methanol and successively 
washed with deionized water until the pH of the suspension reached neutral. The precipitate was 
dried by lyophilization. The molecular weight of PSI was determined by gel permeation 
chromatography (Breeze 2 GPC, Waters), with Styragel® HT column (Waters). 
N,N-dimethylformamide (DMF) containing 20 mM LiBr was used as the eluent, with the elution 
rate of 1 ml min-1. Polystyrene standards were used for calibration. Mn = 13,600 g mol-1 with 
PDI = 1.4. 
149 mg purified PSI was dissolved in 8 ml N,N-dimethylformamide (DMF, Fisher 
Scientific), and octadecylamine (6, 22, and 44 mg for DS-2.4, DS-6.4, and DS-14.8, respectively) 
was added to the reaction mixture. The reaction was stirred at 70 °C for 24 hours. Next, excess 
amount of ethanolamine (272, 261, 247 µL for DS-2.4, DS-6.4, and DS-14.8, respectively) was 
added and the reactant was further stirred at 45 °C overnight. Following completion of the 
chemical reactions, the products were dialyzed (MWCO 3500 Da, Fisher Scientific) extensively 
in deionized water at room temperature for two days and then lyophilized to yield dry powders. 
3.4.2 Characterizations of PHEA-C18 polymers 
1H NMR (Varian Unity 500 MHz) was applied to analyze the polymer dissolved in 
DMSO-d6 (Cambridge Isotope Laboratories, Inc.). The integrals of characteristic peaks were 
used to quantify the degree of substitution of octadecyl chains (DSC18) in each sample by Eq. (4) 
V (mol%) =        . .  ! "⁄      $."$.% ! × 100 %  Eq. (4) 
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3.4.3 Measurement of the critical micelle concentration (CMC) 
Pyrene molecules (Acros) were suspended in the polymer solution at a concentration of 10-4 
mg/ml. The fluorescent spectra of the suspensions with varying polymer concentrations were 
collected using a FluoroMax®-4 spectrometer (HORIBA Jobin Yvon). The excitation wavelength 
was set at 330 nm and the resulting emission between 350 and 450 nm was collected; the slit 
widths for excitation and emission were both set as 1 nm. The CMC was determined by the 
polymer concentration at the point where the emission intensity ratio (I3/I1) between the third 
vibronic peak at 385 nm (I3) and the first vibronic peak at 373 nm (I1) was significantly 
increased.15 
3.4.4 Preparation of PHEA-g-C18 micelles 
The PHEA-g-C18 polymer was suspended in PBS at a concentration of 0.1 mg/ml and 
sonicated briefly to make a homogeneous colloidal solution. PHEA-g-C18 micelles formed 
spontaneously after the sonication. 
3.4.5 Morphological and size analysis of PHEA-g-C18 micelles 
The micelle suspension was dropped onto a 300-mesh copper grid coated with carbon and 
formvar (SPI Supplies), and the sample was stained with 2 % (w/v) phosphotungstic acid 
solution (adjusted to pH 7.4 with NaOH). Then the morphology of self-assembled PHEA-g-C18 
micelles was observed using TEM (JEOL 2100 with LaB6 emitter) operating at an accelerating 
voltage of 120 keV. Separately, the diameter of PHEA-g-C18 micelles was measured using a 
Malvern Zetasizer Nano ZS instrument (Malvern, 4 mW He-Ne laser operating at a wavelength 
of 633 nm) with 173° backscattering. The hydrodynamic radius was determined using Cumulant 
analysis.27 All measurements were carried out in triplicate and performed at 25°C. 
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3.4.6 Synthesis of Staphylococcus aureus protein A coupled with palmitic acid (SpA-PA) 
The chemical conjugation of palmitic acid to SpA has been reported previously.28 In short, 
SpA was suspended at 1 mg/ml in PBS containing 0.3 % sodium deoxycholate (DOC), 0.1 % 
sodium bicarbonate, and 0.1 % sodium azide. N-hydroxysuccinimide ester of palmitic acid 
(NHS-PA) was dissolved in ethanol at 10 mg/ml and added to the protein solution to yield a final 
concentration of 0.1 mg NHS-PA per ml. This mixture was incubated at room temperature for 24 
h with constant mixing, and then purified with a centrifugal filter (Amicon® Ultra 3K device, 
Millipore Corporation). The product was adjusted to 1 mg/ml in PBS with 0.1 % DOC. 
3.4.7 SpA-PA labeled with fluorescein 
400 µl SpA-PA was suspended in PBS at 2.73 mg/ml, and 12.96 µl FITC solution (10 
mg/ml in DMSO) was added into the SpA-PA suspension. The mixture was incubated at room 
temperature in the dark for 40 minutes, while keep stirring it. Afterward, the solution was 
dialyzed in a dialysis cassette (Thermo Scientific, MWCO 3000) against PBS at 4 °C for two 
days. Finally, the product was concentrated with a centrifugal filter (Amicon® Ultra 3K device, 
Millipore Corporation) and re-suspended in PBS containing 0.1% NaN3 at a concentration of 
1.26 mg/ml. 
3.4.8 Antibody labeled with rhodamine 
150 µL VCAM-1 antibody solution (CD106) at 500 µg/ml PBS was mixed with 30.15 µL 
rhodamine B isothiocyanate at 5 mg/ml DMSO, and the mixture was incubated at room 
temperature in the dark for 2 hours. The excess free rhodamine was removed by dialyzing the 
raw product against PBS at 4 °C for 2 days, and then the sample was concentrated with a 
centrifugal filter (Amicon® Ultra 3K device, Millipore Corporation). The concentrate was 
re-suspended with PBS equal to the antibody concentration at 500 µg/ml. 
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3.4.9 Coupling of PHEA-g-C18 micelles with SpA-PA, association percentage of SpA-PA, 
and FRET analysis 
500 µl of PHEA-g-C18 solution (0.1 mg/ml PBS) and 10 µL of SpA-PA labeled with 
fluorescein were mixed and sonicated briefly. Then the mixture was incubated at a designated 
temperature (277, 294, or 310 K; 294 K if not specified) for 10 min, and purified with a 
centrifugal filter (Amicon® Ultra 100K device, Millipore Corporation). The concentrate was 
added with PBS equal to the weight spun off during the ultracentrifugation to make the final 
sample.  
For studying the association percentage of SpA-PA, part of the sample was taken out as the 
control before the ultracentrifugal purification. Both the control and the final sample were 
measured with the fluorescence emission intensity at 535 (± 20) nm at the excitation of 485 (± 
20) nm, using a microplate reader (Infinite 200Pro, Tecan Group Ltd.). The association 
percentage of SpA-PA, defined as the ratio of the amount of SpA-PA associated with the micelle 
to the amount of SpA-PA added in prior the assembly process, was calculated from the ratio of 
fluorescence of the final sample to the control. For FRET analysis, 250 µl of the final sample was 
mixed with 12 µL VCAM-1 antibodies labeled with rhodamine or mixed with 12 µL PBS as the 
control. Micelle samples mixed with antibodies and those without were measured with the 
fluorescence emission intensity in the rage of 500 to 700 nm at the excitation of 490 nm using 
FluoroMax®-4 spectrometer (HORIBA Jobin Yvon). 
3.4.10 Measurements of micelles bound to target proteins using surface plasmon 
resonance (SPR) spectroscopy 
A gold sensor chip (GE Healthcare, USA) was modified to present a 
11-mercaptoundecanoic acid (MUA) monolayer by imersing the chip in 1 mM MUA solution 
overnight to form a self-assembly monolayer. The carboxylic groups of the MUA monolayer 
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were then activated by injecting the mixture of 0.4 M 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, Thermo Scientific) and 0.1 M 
N-hydroxysuccinimide (NHS) (1:1, v/v) into the flow cell in a Biacore 3000 (GE Healthcare) for 
five minutes at 5 µl/min. After activation, recombinant human VCAM-1 (R&D Systems) or 
recombinant human integrin αvβ3 (R&D Systems) was chemically linked to the MUA layer by 
flowing the solution at 2 µl/min until the response unit was saturated. The remaining NHS-ester 
groups on the MUA surface were blocked by injecting 1.0 M ethanolamine into the flow cell at 5 
µl/min. 
SpA-PA-coupled micelles coated with or without antibodies at a concentration of 0.1 mg/ml 
PBS were injected into the flow cell to examine the association and dissociation rates of the 
micelles with the gold sensor chip modified with the target protein on MUA. The media flow 
rate was kept constant at 5.0 µL/min. RUdisso was defined as the RU reading at the third minute 
after the sample injection stopped. The kinetic data from SPR sensorgrams were obtained with 
the assistance of BIAevaluation version 4.1. 
3.4.11 PHEA-g-C18 micelles labeled with rhodamine  
1 ml PHEA-g-C18 dissolved in 10 mg/ml dimethyl sulfoxide (DMSO) was mixed with 0.135 
ml rhodamine B isothiocyanate dissolved in 10 mg/ml DMSO. The mixture was incubated at 
room temperature in the dark for 24 hours. The excess rhodamine was removed by dialyzing the 
raw product against water for 3 days. Then, the sample was lyophilized to get a power product. 
3.4.12 Analysis of the micelle adhesion onto a protein-coated substrate in a flow 
chamber 
Integrin αvβ3 was coated onto the bottom of a 35 mm petri-dish, which was then assembled 
with the gasket (GlycoTech) and exposed the coated substrate to a flow at an average velocity of 
1 mm/s. The suspension of PHEA-g-C18 micelles labeled with rhodamine was injected into the 
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chamber via a syringe pump (KDS 100 Infusion Pump, KD Scientific), and the micelles were 
circulated for 10 min followed by an injection of PBS to remove unbounded micelles. The 
adhesion of micelles to the substrate was examined by capturing fluorescence from the substrate 
using a confocal microscope (Leica SP2). Finally, the fluorescence was quantified with ImageJ 
(NIH). Five different areas of the substrate were analyzed with at least three different samples 
per condition. 
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3.6 Figures 
 
Figure 3.1. Schematic description
PHEA-g-C18 micelle using the alkylated 
SpA-PA.  
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 of a strategy to immobilize antibodies on the surface of 
Staphylococcus aureus protein A
 
 (SpA), termed 
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Figure 3.2. Assembly of nano-sized micelles using PHEA-g-C18 with controlled DSC18 (a) 
The reaction scheme of synthesizing PHEA-g-C18. (b) TEM micrographs of DS-2.4 (b-1), 
DS-6.4 (b-2), and DS-14.8 micelles (b-3). Scale bar is 200 nm. DS-2.4, DS-6.4, and DS-14.8 
represent PHEA-g-C18 at DSC18 of 2.4, 6.4, and 14.8 mol%. (c) The zeta-potential of the micelles 
with varied DSC18 in PBS. 
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Figure 3.3. 1H NMR spectra of PHEA-g-C18 polymers with DSC18 of 2.4 mol % (a), DSC18 of 6.4 
mol % (b), and DSC18 of 14.8 mol % (c) in DMSO-d6. In the spectra, every characterization peak 
was assigned according to the polymer chemical structure.   
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Figure 3.4. Fluorescent analysis to determine critical micelle concentrations (CMCs) of 
PHEA-g-C18 polymers with DSC18 of 2.4 mol % (a), DSC18 of 6.4 mol % (b), and DSC18 of 14.8 
mol % (c) in PBS.  The pyrene molecules were incorporated into the mixture of PHEA-g-C18 and 
water to determine CMCs marked by the onset of increasing I3/I1, where I3 and I1 represent the 
pyrene emission intensity measured at wavelengths of 385 and 373 nm, respectively.  
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Figure 3.5. Assembly of PHEA-g-C18 micelles coupled with SpA-PA. (a) (a-1) Reaction 
scheme of conjugating palmitic acid to SpA. (a-2) Hydrophobic interaction-induced self-assembly 
between SpA-PA and PHEA-g-C18. (b) Fluorescence analysis to evaluate effects of DSC18 of 
PHEA-g-C18 micelles on the percentage of SpA-PA associated with micelles suspended in PBS.  
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(Continued from the previous page) 
For this analysis, SpA-PA was labeled with fluorescein. (c) ∆G underlying the self-assembly 
between SpA-PA with DS-2.4 (filled triangles) or DS-14.8 (open squares) in PBS. ∆G was 
calculated from Keq using Eq. (1), and Keq was quantified from the association percentage of 
SpA-PA presented in (b) using Eq. (1). (d) Van’t Hoff plot for self-assembly between SpA-PA and 
DS-2.4 (filled triangles) and DS-14.8 (open squares) micelles in PBS. (e) ∆S (open bars) and ∆H 
(filled bars) underlying the self-assembly process of SpA-PA with DS-2.4 and DS-14.8 micelles in 
PBS. ∆S and ∆H were calculated from (d) and Eq. (2).  
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Figure 3.6. FRET analysis of the biological coupling of antibody to PHEA-g-C18. (a) 
Schematic description of the FRET assay designed to characterize the binding between the 
fluorescein-conjugated SpA-PA and the rhodamine-labeled antibody on the micelle surface. (b) 
Fluorescence emission spectra of SpA-coupled micelles mixed with VCAM-1 antibodies right 
after mixing. (b-1) Mixture of SpA-PA-coupled DS-2.4 micelles with antibodies (red curve) and 
without antibodies (black curve). (b-2) Mixture of SpA-PA-coupled DS-14.8 micelles with 
antibodies (red curve) and without antibodies (black curve). (c) The degree of FRET (DFRET) for  
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(Continued from the previous page) 
the mixture of antibodies with SpA-PA-coupled DS-2.4 micelles (filled bars) or with 
SpA-PA-coupled DS-14.8 micelles (open bars) right after mixing (0 min) and after incubation in 
PBS for 60 min, respectively.    
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Figure 3.7. SPR analyses of PHEA-g-C18 micelles coated with or without antibodies to 
VCAM-1 or integrin αvβ3. (a) Schematic SPR configuration for studying the binding between  
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(Continued from the previous page) 
antibody-coated PHEA-g-C18 micelles and the MUA substrate coupled with target proteins. (b) 
SPR sensorgrams for binding of SpA-PA-coupled DS-14.8 micelles coated with corresponding 
antibodies (solid line) and without antibodies (dashed line) to the substrate coupled with VCAM-1 
(b-1) and integrin αvβ3 (b-2). (c) SPR sensorgrams for binding of SpA-PA-coupled DS-2.4 
micelles coated with corresponding antibodies (solid line) and without antibodies (dashed line) to 
the substrate coupled with VCAM-1 (c-1) and integrin αvβ3 (c-2). (d) RU after the injection 
(RUdisso) for SpA-PA-coupled DS-14.8 micelles (d-1) and DS-2.4 micelles (d-2) coated with 
antibodies (filled bars) and without antibodies (open bars) to the substrate coupled by VCAM-1 
and integrin αvβ3 in (b) and (c). 
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Figure 3.8. SPR sensorgrams for binding of SpA-PA-coupled DS-14.8 micelles coated by 
antibodies to VCAM-1 (black line) and DS-14.8 mcelles simply mixed with antibodies (red line) 
with the substrate conjugated with VCAM-1.  
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Figure 3.9. In vitro analysis of the targeted adhesion of SpA-PA-coupled DS-14.8 micelles in 
a flow chamber. (a) Schematic of the flow chamber. (b) Confocal micrographs of integrin 
αvβ3-coated substrate in the flow chamber following exposure to SpA-PA-coupled micelles coated 
by antibodies to αv (b-1) and micelles free of antibodies (b-2). (c) Quantitative analysis of the 
number of SpA-PA-coupled DS-14.8 micelles adhered to integrin αvβ3-coated substrate. The 
differences of the fluoresce area percentages between the two conditions were statistically 
significant (p* < 0.05). Each value and error bar in the plot represents the mean and standard 
deviation from at least four different areas of the substrate in three different samples per condition. 
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3.7 Tables 
Table 3.1. Analysis of the chemical structure and the critical micelle concentration (CMC) of 
PHEA-g-C18, and the hydrodynamic radius of PHEA-g-C18 micelles 
Sample DSC18 
(mol %)a 
CMC  
(mg/ml)b 
Hydrodynamic 
radius of micelles 
(nm)c 
DS-2.4 2.4 2.0×10-2 103 
DS-6.4 6.4 1.0×10-2 116 
DS-14.8 14.8 0.8×10-2 138 
a Determined based on 1H NMR spectra of the polymer 
b Determined based on fluorescent emission spectra of pyrene in PBS 
c Determined with a dynamic light scattering unit  
  
73 
Chapter 4 Improved Electrocatalytic Performance of Platinum 
Nanocubes by Different Preparation Approaches of Polymer-Nanocubes 
Nanoconstructs 
4.1 Introduction 
Platinum (Pt) is the most effective catalyst known to increase the rate of hydrogen oxidation 
and oxygen reduction to date, and Pt nanoparticles supported on porous carbon (Pt/C) is 
considered as the best electrocatalyst in proton exchange membrane fuel cells and phosphoric 
acid fuel cells.1 Achieving a higher catalytic activity than the standard Pt/C catalyst used in 
current fuel cells is one of the keys to enable the fuel cells feasible for commercialization. Pt/C 
catalyst can be prepared by impregnation method,1, 2 microemulsion method,2, 3 and colloidal 
method.1, 2 Specifically, the colloidal method, preparing the Pt colloid followed by adsorption of 
Pt on the carbon support, has the advantage of providing a precise size control of Pt 
nanoparticles.1, 4  
Compared to the commercial Pt catalyst, Pt nanocubes have been shown to exhibit an 
enhanced electrocatalytic activity and over 2-fold specific activity for oxygen reduction.5, 6 
Therefore, it is intriguing to find an effective approach to immobilize Pt nanocubes on a solid 
support of interest. Several conventional methods have been proposed to immobilize colloidal Pt 
nanoparticles from the solution onto the surface of solid supports by chemical conjugation,7, 8 
hydrogen bonding interaction,9, 10 electrostatic adsorption,11 and ligand coordination.12 However, 
these methods have not been proved applicable to Pt nanocubes immobilization, and potential 
challenges are anticipated: a suitable capping material is needed for the successful synthesis of 
homogeneous colloidal Pt nanocubes and for serving as the binding interface of immobilizing the 
nanocubes on a solid support at the same time. This is challenging because how the precursors, 
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capping molecules, or additives operate mechanistically in the shape formation has not been well 
understood.6  
To resolve these challenges, we proposed that different preparation approaches of the 
nanoconstructs composed of polymeric micelles and Pt nanocubes will affect the electrocatalytic 
performance of Pt by controlling the nanocubes distribution in the polymer matrix (Figure 4.1). 
We examined this hypothesis by 1) associating Pt nanocubes with 200 nm particles of 
poly(2-hydroxyethyl aspartamide) substituted with octadecyl chains, termed PHEA-g-C18, by a 
slow-evaporation method, and 2) stabilizing the Pt nanocube clusters with PHEA-g-C18 in 
aqueous by emulsification. The Pt nanocubes associated with or on the PHEA-g-C18 micelles 
were dominated by the removal rate of hexane, which is a good solvent for Pt nanocubes but a 
selective solvent for PHEA-g-C18. The electrocatalytic performance of Pt-PHEA-g-C18 samples 
was evaluated with cyclic voltammetry (CV), and the sample coated on the electrode was further 
analyzed with scanning electrode microscopy (SEM) to elucidate the underlying mechanism of 
the improved electrocatalytic performance from the slow-evaporation sample. Taken together, 
the results of this study will greatly serve to advance the understanding that how preparation 
methods can control the Pt nanocubes distribution in polymer matrix and can further affect the 
distribution of Pt nanocubes on the carbon support, which ultimately lead to improving the 
electrocatalytic efficiency of current Pt catalyst on the carbon support from a different point of 
view.  
 
4.2 Results 
4.2.1 Synthesis and characterization of PHEA-g-C18 and platinum (Pt) nanocubes 
As mentioned in Chapter 3.2.1, PHEA-g-C18 was synthesized through nucleophilic 
substitution of the designated amount of octadecylamine and excessive amount of ethanolamine 
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to poly(succinimide), and its structure was characterized with 1H NMR spectroscopy. The degree 
of substitution for octadecyl chains (DSC18) to the polymer, defined as the mole percentage of 
succinimide units substituted with octadecyl chains, was determined to be 14.8 mol % in this 
study. For convenience, PHEA-g-C18 at DSC18 of 14.8 mol % was termed as DS-14.8. On a 
separate note, Pt nanocubes were synthesized by a modified approach based on the previous 
study,5 and the structure of Pt nanocubes was characterized by transmission electron microscopy 
(TEM) (Figure 4.2). 
4.2.2 Slow-evaporation method and emulsification for preparing Pt-PHEA-g-C18 
Pt-PHEA-g-C18 nanoconstructs were prepared by two different approaches (Figure 4.1). In 
the slow-evaporation method, 200 nm sized particles of PHEA-g-C18 was first self-assembled in 
aqueous media. Then Pt nanocubes solution was added into the micelle solution (Figure 4.3a), 
and this mixture was stirred vigorously to make a vortex which continuously brought the Pt 
nanocubes to mix with the PHEA-g-C18 micelle (Figure 4.3b). The mixing proceeded until all 
the hexane evaporated out. In the emulsification method, PHEA-g-C18 in aqueous media mixed 
with Pt in hexane, at the same ratio as used in the slow-evaporation approach, were sonicated to 
form a homogenous cloudy emulsion. Then the hexane was quickly removed out of the mixture 
by a rotary evaporator (Figure 4.1b). The Pt-PHEA-g-C18 samples prepared by both methods 
had a brownish color (Figure 4.3c). 
TEM micrographs confirmed the morphology of Pt-PHEA-g-C18 nanoconstructs prepared 
by two different methods. The nanoconstruct prepared by the slow-evaporation method had a 
dominating morphology of Pt nanocube clusters, of which the shape was either spherical or close 
to spherical and the observed packing density of Pt nanocubes was dense (Figure 4.4a). In 
contrast, Pt-PHEA-g-C18 nanoconstructs prepared by emulsification had loosely spreading of Pt 
nanocubes in different domains of PHEA-g-C18 polymers (Figure 4.4b). 
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4.2.3 Electrocatalytic performance of Pt nanocubes examined with cyclic voltammetry 
(CV) 
Cyclic voltammetry (CV) was used to study the electrocatalytic properties of Pt nanocubes on 
the electrode, prepared by drop casting of the Pt-PHEA-g-C18 samples on the carbon support 
surface. The cyclic voltammograms of the samples prepared by two approaches were found to be 
very different in terms of the shape and the current intensity of the measured curves of currents 
versus scan rates (Figure 4.5a). In oxidation reaction, no peak currents and increased current 
densities were presented in the Pt-PHEA-g-C18 sample prepared by the slow-evaporation method, 
while peak currents were observed in the emulsification sample. The higher current density from 
the slow-evaporation sample signified more electrocatalytic activities than that from the 
emulsification sample. Furthermore, Randles-Sevcik equation was applied to analyze the actual 
active area by peak current in the oxidation current (ip of the slow-evaporation sample was 
assumed as the highest current in the voltage range from 0 to 0.6 V): 
WX = (2.69 × 10)\.].^_. Eq. (1) 
where n is the number of electrons transferred in the redox event, A is the electrode surface area or 
actual active area (cm2), D and C is the diffusion coefficient (cm2/s) and the concentration of the 
electroactive species in the bulk solution (mol/cm3), respectively, and ν is the scan rate (V/s).  
ip was proportional to the square root of ν. From the slope of ip versus ν0.5 plots (Figure 4.5b), 
given that n, D, and C were constant as all the experiments were conducted under the identical 
conditions, the actual active area of the slow-evaporation sample was about 2.5-folds of the 
emulsification sample as measured by CV. 
4.2.4 Electrode surface study with SEM  
The macroscopic distribution of Pt nanocubes on the carbon substrate coated with 
Pt-PHEA-g-C18 samples prepared by two methods was examined with SEM. Two distinguished 
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domains, the carbon and the Pt-PHEA-g-C18 coated carbon, were observed on the electrode 
surface coated with the slow-evaporation sample. SEM-EDX confirmed the bright region (Area 
1, Figure 4.6) contained a higher percentage of Pt nanocubes than the dark region (Area 2, 
Figure 4.6) in the low-magnification micrograph of the electrode surface. The local brightness 
on the SEM micrograph clearly indicated the carbon surface were coated by platinum nanocubes 
or not, even without further EDX analysis. 
By zooming in the bright region of the low-magnification micrograph of the 
slow-evaporation sample (1st row in Figure 4.7a), the Pt nanocubes were observed to be 
wide-spreading on the carbon support of the electrode. Pt nanocubes formed small islands 
scattering on the carbon support in the dark region of the low-magnification micrograph of the 
slow-evaporation sample (2nd row in Figure 4.7a). In contrast, neither huge coverage nor small 
islands of Pt nanocubes was found on the electrode surface coated with the emulsification sample 
(Figure 4.7b).  
 
4.3 Discussion 
Overall, this study demonstrates a novel method to improve the electrocatalytic activity of 
Pt nanocubes using PHEA-g-C18 as the matrix, which was then coated on the carbon support. 
The electrocatalytic activity of the Pt-PHEA-g-C18 was improved by decreasing the hexane 
removal rate when the sample was prepared with the two phase mixture, composed of Pt 
nanocubes in hexane and PHEA-g-C18 in water. We found that the sample prepared by a 
slow-evaporation method led to higher measured current densities and no peak current in CV 
measurements than that prepared by the emulsification method, where a rotator evaporator was 
used to quickly remove the hexane. A higher Pt nanocubes coverage on the electrode coated with 
slow-evaporation sample was observed with SEM than that with the emulsification sample. The 
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well-dispersed Pt nanocubes on the electrode supported the improved electrocatalytic 
performance of the Pt-PHEA-g-C18 prepared by the slow- evaporation method.  
PHEA-g-C18 is not expected to self-assemble into micelles with a perfect hydrophilic 
exterior in aqueous media, due to its randomly grafted polymer architecture. Randomly modified 
polymers have been proposed to associate in a manner that hydrophobic and hydrophilic parts of 
the polymer are entangled together which results in the possible contact between the core and the 
aqueous media.13 Therefore, Pt nanocubes with a hydrophobic coating layer can start to associate 
spontaneously with the exposing hydrophobic domain of PHEA-g-C18 micelles during the 
hexane-removal process. Additionally, the polymeric micelle integrity was minimally disrupted 
by hexane during the slow-evaporation process considering two factors. First, hexane is not a 
good solvent for PHEA-g-C18 hydrophilic polymer backbones, which help resist the hexane to 
solvate the polymeric micelles. Secondly, hexane has a high air/water partition coefficient,14 
which indicates the great tendency of hexane to evaporate out compared to stay in aqueous phase 
and solvate the micelles. 
Though it is not straightforward to observe Pt nanocubes coated on the outside of 
PHEA-g-C18 micelles prepared by the slow-evaporation method from TEM micrographs, 
different Pt distribution patterns in PHEA-g-C18 were observed for the two PHEA-g-C18 
nanoconstructs. For emulsification method, PHEA-g-C18 started to self-assemble after the energy 
input of sonication was applied to form the stable emulsion. Hexane was removed quickly to 
make PHEA-g-C18 nanoconstructs before the emulsion became unstable. However, this quick 
method yielded a less dense clustering of Pt nanocubes, as shown in the TEM micrographs, 
compared to the slow-evaporation method. 
The nanostructure feature of the slow-evaporation sample led to improved electrocatalytic 
performances, including higher current densities and no peak current in CV measurements. The 
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CV results indicated no mass-transfer limit of the electroactive species and three-dimensional 
diffusion happened in measuring the slow-evaporation sample, both of which are typical 
characteristics of nano-sized materials on the electrode. It suggested the exposure of the Pt 
nanocubes on the electrode surface. The macroscopic distribution of Pt nanocubes on the carbon 
surface of the electrode was further examined with SEM to study the electrocatalytic 
performance improvement of the slow-evaporation sample. The high coverage of immobilized Pt 
nanocubes formed on the electrode surface coated with the slow-evaporation sample, because 
PHEA-g-C18 helped carry the nanocubes to spread on the porous carbon effectively by serving as 
nanocarriers to prevent the instability of the nanocubes during the preparation process. Even 
though we expected PHEA-g-C18 in the emulsification sample played a similar role, the Pt 
nanocubes distributed inside of the nanoconstructs compromised the electrocatalytic 
performances. 
 
4.4 Conclusion 
This study describes a novel concept that preparing Pt nanocubes associated with and 
loaded in polymeric micelles can lead to the different electrocatalytic performance of Pt, due to 
the changed distribution of Pt nanocubes on the CV electrode surface. The removal rate of 
hexane, in which colloidal Pt nanocubes was originally suspended, of the preparation methods 
determined the effectiveness of this polymer-assisted strategy for the nanocube coating on the 
electrode. Pt nanocubes mixed with PHEA-g-C18 was studied as the model system. The 
nanoconstructs prepared by the slow-evaporation method has led to a distinct spatial organization 
of the Pt nanocubes coated on the polymeric micelles, resulted in 2.5-folds higher 
electrocatalytic activity as examined with CV, and showed a higher surface coverage of the Pt 
nanocubes on the electrode surface than those prepared by emulsification. Overall, we envisage 
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this study will advance the understanding that how the interaction between Pt nanocubes and the 
supporting polymeric micelles can improve the electrocatalytic efficiency of Pt catalyst on the 
carbon support of electrodes. This study is important for immobilizing heterogeneous catalysts 
on a substrate of interest using colloidal method. 
 
4.5 Experimental Section 
All chemicals and materials were purchased from Sigma-Aldrich (USA/Korea) and used without 
further purification unless otherwise specified. 
4.5.1 Synthesis of and characterization of poly(2-hydroxyethyl-co-octadecyl 
aspartamide) (PHEA-g-C18) 
Refer to Experimental Sections of Chapter 3 (Section 3.5.1). 
4.5.2 Preparation of PHEA-g-C18 micelles 
The PHEA-g-C18 polymer was suspended in cell-culture grade water at a concentration of 2 
mg/ml and sonicated briefly to make a homogeneous colloidal solution. PHEA-g-C18 micelles 
formed spontaneously after the sonication.  
4.5.3 Synthesis of platinum (Pt) nanocubes 
Pt(acac)2 (0.1 g), octadecene (10 ml), oleic acid (OA) (1 ml), and oleylamine (OAm) (1 ml) 
were mixed under N2 and magnetic stirring. The mixture was then heated to 120 °C and kept in 
30 minutes. A solution of Fe(CO)5 in hexane (0.1 ml, prepared by adding 0.1 ml Fe(CO)5 in 1 ml 
hexane) was injected into the solution. The solution was further heated to 200 °C and kept at this 
temperature for 1 hour before it was cooled down to room temperature (heating rate: 240 °C/h). 
40 ml of isopropanol was added and then the suspension was centrifuged (8000 rpm, 10 min) to 
separate the nanoparticles. The particles were dispersed in 10 ml hexane and precipitated out by 
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adding ethanol, then the suspension was centrifuged again (8000 rpm, 10 min). The final product 
(50 mg) was dispersed in 10 ml of hexane for further use. 
4.5.4 Slow evaporation method for preparing Pt-PHEA-g-C18 nanoconstructs  
9 ml platinum nanocubes (1.8 mg/ml hexane) were mixed with 8 ml PHEA-g-C18 micelle 
solution (2 mg/ml), and this mixture was stirred vigorously in the hood over 30 hours to ensure 
all the hexane evaporated out. The sample was a brownish solution, and then lyophilized to yield 
dry powders for the following experiments. 
4.5.5 Traditional emulsification method for preparing Pt-PHEA-g-C18 nanoconstructs 
PHEA-g-C18 in aqueous was mixed with Pt nanocubes in hexane at the same ratio as 
described in the slow-evaporation approach. The mixture was sonicated to form a homogenous 
cloudy emulsion, and then the hexane was quickly removed out of the mixture by a rotary 
evaporator. The sample was also a brownish solution, and then lyophilized to yield dry powders 
for the following experiments. 
4.5.6 Morphological analysis of Pt nanocubes and Pt-PHEA-g-C18 nanoconstructs 
The sample suspension was dropped onto a 300-mesh copper grid coated with formvar 
(Electron Microscopy Sciences) and air-dried. Then the morphologies of Pt nanocubes and 
Pt-PHEA-g-C18 nanoconstructs were observed using TEM (JEOL 2100 with LaB6 emitter) at an 
accelerating voltage of 200 keV. 
4.5.7 Electrode preparation and procedure of cyclic voltammetry (CV) 
Pt-PHEA-g-C18 sample was dissolved in ethanol (99 %) at 3.5 mg/ml with a mild sonication 
(Lab companion, Korea, 40 kHz) for 20 seconds. A drop of 50 µL sample was coated on the 
working electrode (surface area of 2.54 cm2), composed of titanium foil (0.25 mm thickness) and 
covered by a carbon paste (ELCOAT CX-12, CANS, JAPAN), and then was air-dried at 70 °C for 
1 hour.  
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The electrochemical property of the coated film was investigated by a (PARSTAT 2273A, 
Princeton Applied Research, USA) with 10 mmol K3Fe(CN)6 and 100 mmol KNO3 solution as the 
electrolyte. Platinum mesh and Ag/AgCl, KCl (sat’d.) were used as the auxiliary and the reference 
electrode, respectively. Then, the cyclic voltammetry was examined by the three-electrode cell at a 
voltage scan rate of 10-200 mV/s at room temperature. The electrode with only carbon paste 
without sample coating was tested under the same conditions as the background signal, which was 
subtracted from all the other sample measurements. Four times of pre-scans were run at a scan rate 
of 100 mV/s before the measurement. CV measurement was repeated for the same sample on the 
1st, 2nd, and 9th day after the electrode was coated. The electrocatalytic stability was well 
maintained during this period as the measured curves remained similar (data not shown).  
4.5.8 Surface analysis of electrodes with SEM 
The surface morphology of Pt-PHEA-g-C18 nanoconstructs on the electrode, after CV 
measurements, was observed using FEI Helios 650 Nanolab FEI/SEM (FEI, Eindhoven, 
Netherlands) operating at an accelerating voltage of 5 keV to seek the area of interest. The element 
analysis was performed using Energy dispersive X-ray spectroscopy with same equipment. 
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4.7 Figures 
 
Figure 4.1. Schematic description of two disparate strategies to load Pt nanocubes on or in 
the PHEA-g-C18 micelles. (a) Slow-evaporation method enabling the localization of Pt 
nanocubes on the micelle surface. (b) Emulsification to load Pt nanocubes within the micelle. 
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Figure 4.2. Characterization of Pt nanocubes. (a) TEM image of the Pt nanocubes. (b) High 
resolution TEM image of Pt nanocubes. The scale bar in (a) and (b) represents 20 nm and 5 nm, 
respectively. 
 
 
Figure 4.3. The slow-evaporation method and the resulting samples. (a) A photograph of the 
Pt solution mixed with the PHEA-g-C18 micelle solution without stirring. (b) A photograph and a 
scheme showing the two components in (a) were mixed continuously by vigorously stirring. (c) A 
photograph of the colloidal samples of Pt-PHEA-g-C18 prepared by emulsification (left) and the 
slow-evaporation method (right).   
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Figure 4.4. Morphological analysis of the spatial organization of Pt nanoparticles on or in 
PHEA-g-C18 micelles with TEM. Pt-PHEA-g-C18 nanoconstructs prepared by the 
slow-evaporation method (a) and emulsification (b). The scale bar represents 100 nm. 
(a) (b)
Figure 4.5. Analysis of electrocatalytic activities for Pt nano
PHEA-g-C18 micelles. (a) Cyclic voltammograms of the 
slow-evaporation method (a-1) and 
Pick current analysis of the samples 
triangles) and the traditional emulsification
curves.   
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cubes loaded on or in 
Pt-PHEA-g-C18 samples prepared 
emulsification (a-2) measured at different scanning rate
prepared by the slow-evaporation method (
 (black dots). Lines in (b) represent the linear fitting 
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Figure 4.6. SEM-EDX for the surface elemental analysis of the bright region (Area 1) and the dark 
region (Area 2) on the SEM micrograph of 
nanoconstructs which were prepared by 
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the electrode coated with 
the slow-evaporation method. Scale bars
 
Pt-PHEA-g-C18 
 represent 2 µm. 
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Figure 4.7. Surface analysis of electrodes deposited by PHEA-g-C18 micelles with the 
controlled spatial organization of Pt nanocubes (a) SEM micrographs of the electrode coated 
with Pt-PHEA-g-C18 nanoconstructs prepared by the slow- evaporation method. The scale bar on 
the 1st column represents 2 µm, and scale bars on the images displayed on the 2nd and 3rd columns 
represent 100 nm. Yellow circles on the center micrograph of the 2nd columns represent Pt islands. 
(b) SEM micrographs of the electrode coated with Pt-PHEA-g-C18 nanoconstructs prepared by 
emulsification. The scale bar on the image of the 1st column represents 20 µm, and the scale bar on 
the image of the 2nd column represents 100 nm. 
  
(a)
(b)
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Chapter 5 Conclusion and Future Work 
The goal of this dissertation research is engineering an amphiphilic polyaspartamide to 
prepare nanocarriers of 1) imaging contrast agents and 2) catalytic Pt nanocubes to achieve the 
improved targetability and lifetime and the enhanced Pt electrocatalytic performance, 
respectively. These projects inherently take advantage of the polyaspartamide characteristics: the 
easy functionalization of the starting polysuccinimide by grafting different side groups of interest 
onto the backbone via aminolysis, and the low expense of preparing polyaspartamide (neither 
vacuum nor catalyst needed), compared to block copolymers. 
 In chapter 2, we hypothesized that decreasing the bilayer permeability of PHEA-C18-MA 
polymersomes can stabilize their structure, extend their lifetime in circulation, and hence 
improve the quality of bioimaging when the polymersome was coupled with an imaging probe. 
The bilayer permeability of the polymersome was decreased by increasing the packing density of 
the bilayer with methacrylate groups, and was further decreased by inducing chemical 
cross-linking reactions between the methacrylate groups. The polymersome with the decreased 
bilayer permeability demonstrated greater particle stability in physiological media, and 
ultimately can better highlight tumors in mice over two days compared to those with a higher 
bilayer permeability after labeling with a near-infrared (NIR) fluorescent probe.  
 In chapter 3, a simple method was proposed and evaluated to immobilize antibodies that 
can act as targeting motifs on surfaces of nanocarriers by recapitulating a process that bacterium 
adopt for immobilization of the host’s antibodies. We hypothesized that alkylated 
Staphylococcus aureus protein A (SpA-PA) would self-assemble with PHEA-g-C18 micelles and 
subsequently induce stable coupling of antibodies of interest to the micelles. The self-assembly 
between micelles and SpA-PA, confirmed with a fluorescent tag to SpA-PA, was more 
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thermodynamically favorable by increasing the degree of substitution of octadecyl chains to 
PHEA-g-C18 due to a positive entropy change. The final anchorage of antibodies to SpA-PA 
coupled micelles was also corroborated with the fluorescence resonance energy transfer (FRET) 
technique. The micelles coated with corresponding antibodies using SpA-PA as the linker 
displayed the higher binding affinity to a substrate coated by VCAM-1 and integrin αvβ3 than 
antibody-free micelles, as observed with surface plasmon resonance (SPR) spectroscopy.  
Similar results were found with micelles coated with antibodies to integrin αv for a substrate 
coated by integrin αvβ3 in a circulation-mimicking flow chamber. 
 In chapter 4, a method that associating the nanocubes with polyaspartamide micelles, which 
would bring the nanocubes to coat on the electrode, was examined to enable the effective 
immobilization of Pt nanocubes on the carbon solid support. We hypothesized that the removal 
rate of hexane, in which colloidal Pt nanocubes were suspended, determined the effectiveness of 
this PHEA-g-C18 polymer-assisted strategy for the nanocube coating on the electrode. Two 
preparation methods, which have significantly different hexane removal rates, led to distinct 
spatial organizations of the Pt nanocubes with the polymer micelles. The sample prepared by the 
slow evaporation method resulted in 2.5-folds higher electrocatalytic activity than that prepared 
by emulsification, as examined with cyclic voltammetry. Scanning electron micrographs (SEM) 
showed a higher surface coverage of Pt nanocubes on the electrode coated with Pt-PHEA-g-C18 
nanoconstructs prepared by the slow evaporation method than by emulsification, and this 
explained the improved electrocatalytic performance. 
Overall, the results of these projects greatly serve to allow us to better understand the design 
principles of the biocompatible polyaspartamide-derived nanocarriers, and also offer the insight 
about the effect of amphiphilic polyaspartamide interaction with Pt nanocubes on the catalytic 
performance of Pt. 
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Future work based on the research projects in this dissertation is listed as follows: 
Chapter 2 
 Further study the mechanism of polyaspartamide (graft polymer) self-assembly into 
nano-sized polymersomes in the solvent exchange process with theoretical simulation. 
 Functionalize the polymersome surface with targeting motifs to further advance in its 
targetability or/and load therapeutic drugs for the tumor treatment. 
Chapter 3 
 In vivo animal experiment for evaluating the effectiveness of this targeting strategy. 
Chapter 4 
 Further activate the catalyst and remove the polymer matrix after Pt-PHEA-g-C18 coated on 
the electrode; then confirm the catalyst distribution on the electrode and the electrocatalytic 
activity after the activation. 
 Test other amphiphilic materials (e.x. block copolymers) to see if the two preparation 
approaches still generate distinct Pt-PHEA-g-C18 nanoconstructs. 
 Evaluate the degree of hydrophobiclity of PHEA-g-C18 micelle surfaces to further optimize 
the Pt loading capacity and the coating performance on the electrode. 
 
 
